BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer 2020;20:74-88. [PMID: 31686003 DOI: 10.1038/s41568-019-0216-7] [Cited by in Crossref: 235] [Cited by in F6Publishing: 248] [Article Influence: 78.3] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Chi W, Tao L, Wang G, Deepak RK, Sheng L, Chen T, Feng Y, Cao X, Cheng L, Zhao X, Liu X, Deng H, Fan H, Jiang P, Chen L. Ablation of H+/glucose Exporter SLC45A2 Enhances Melanosomal Glycolysis to Inhibit Melanin Biosynthesis and Promote Melanoma Metastasis. Journal of Investigative Dermatology 2022. [DOI: 10.1016/j.jid.2022.04.008] [Reference Citation Analysis]
2 Papadopoli D, Pollak M, Topisirovic I. The role of GSK3 in metabolic pathway perturbations in cancer. Biochim Biophys Acta Mol Cell Res 2021;1868:119059. [PMID: 33989699 DOI: 10.1016/j.bbamcr.2021.119059] [Reference Citation Analysis]
3 Kazyken D, Lentz SI, Fingar DC. Alkaline intracellular pH (pHi) activates AMPK-mTORC2 signaling to promote cell survival during growth factor limitation. J Biol Chem 2021;297:101100. [PMID: 34418433 DOI: 10.1016/j.jbc.2021.101100] [Reference Citation Analysis]
4 Michniewicz F, Saletta F, Rouaen JRC, Hewavisenti RV, Mercatelli D, Cirillo G, Giorgi FM, Trahair T, Ziegler D, Vittorio O. Copper: An Intracellular Achilles' Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics. ChemMedChem 2021;16:2315-29. [PMID: 33890721 DOI: 10.1002/cmdc.202100172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Silva-Pavez E, Tapia JC. Protein Kinase CK2 in Cancer Energetics. Front Oncol 2020;10:893. [PMID: 32626654 DOI: 10.3389/fonc.2020.00893] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
6 Humphreys LM, Smith P, Chen Z, Fouad S, D'Angiolella V. The role of E3 ubiquitin ligases in the development and progression of glioblastoma. Cell Death Differ 2021;28:522-37. [PMID: 33432111 DOI: 10.1038/s41418-020-00696-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Paul R, Bapat P, Deogharkar A, Kazi S, Singh SKV, Gupta T, Jalali R, Sridhar E, Moiyadi A, Shetty P, Shirsat NV. MiR-592 activates the mTOR kinase, ERK1/ERK2 kinase signaling and imparts neuronal differentiation signature characteristic of group 4 medulloblastoma. Hum Mol Genet 2021:ddab201. [PMID: 34274968 DOI: 10.1093/hmg/ddab201] [Reference Citation Analysis]
8 Shi R, Tang Y, Miao H. Metabolism in tumor microenvironment: Implications for cancer immunotherapy. MedComm 2020;1:47-68. [DOI: 10.1002/mco2.6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
9 Uzun S, Korkmaz Y, Wuerdemann N, Arolt C, Puladi B, Siefer OG, Dönmez HG, Hufbauer M, Akgül B, Klussmann JP, Huebbers CU. Comprehensive Analysis of VEGFR2 Expression in HPV-Positive and -Negative OPSCC Reveals Differing VEGFR2 Expression Patterns. Cancers (Basel) 2021;13:5221. [PMID: 34680369 DOI: 10.3390/cancers13205221] [Reference Citation Analysis]
10 Cao M, Luo X, Wu K, He X. Targeting lysosomes in human disease: from basic research to clinical applications. Signal Transduct Target Ther 2021;6:379. [PMID: 34744168 DOI: 10.1038/s41392-021-00778-y] [Reference Citation Analysis]
11 Bustos G, Ahumada-Castro U, Silva-Pavez E, Puebla A, Lovy A, Cesar Cardenas J. The ER-mitochondria Ca2+ signaling in cancer progression: Fueling the monster. Int Rev Cell Mol Biol 2021;363:49-121. [PMID: 34392932 DOI: 10.1016/bs.ircmb.2021.03.006] [Reference Citation Analysis]
12 Ma L, Sun Y, Li D, Li H, Jin X, Ren D. Overexpressed ITGA2 contributes to paclitaxel resistance by ovarian cancer cells through the activation of the AKT/FoxO1 pathway. Aging (Albany NY) 2020;12:5336-51. [PMID: 32202508 DOI: 10.18632/aging.102954] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
13 Zhang Y, Chen X, Lin J, Jin X. Biological functions and clinical significance of long noncoding RNAs in bladder cancer. Cell Death Discov 2021;7:278. [PMID: 34611133 DOI: 10.1038/s41420-021-00665-z] [Reference Citation Analysis]
14 Yi J, Zhu J, Wu J, Thompson CB, Jiang X. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci U S A 2020;117:31189-97. [PMID: 33229547 DOI: 10.1073/pnas.2017152117] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
15 Ahn R, Ursini-Siegel J. Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors. Int J Mol Sci 2021;22:2608. [PMID: 33807608 DOI: 10.3390/ijms22052608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Kumari S, Sikander M, Malik S, Tripathi MK, Hafeez BB, Yallapu MM, Chauhan SC, Khan S, Jaggi M. Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells. Biomedicines 2021;9:1814. [PMID: 34944630 DOI: 10.3390/biomedicines9121814] [Reference Citation Analysis]
17 Chong YC, Toh TB, Chan Z, Lin QXX, Thng DKH, Hooi L, Ding Z, Shuen T, Toh HC, Dan YY, Bonney GK, Zhou L, Chow P, Wang Y, Benoukraf T, Chow EK, Han W. Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma Progression. Hepatol Commun 2020;4:1362-81. [PMID: 32923839 DOI: 10.1002/hep4.1559] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Peng Q, Cheng M, Li T, Chen X, Shen Y, Zhu Y, Xu B. Integrated characterization and validation of the prognostic significance of microRNA-200s in colorectal cancer. Cancer Cell Int 2020;20:56. [PMID: 32099529 DOI: 10.1186/s12935-020-1142-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Ecker V, Stumpf M, Brandmeier L, Neumayer T, Pfeuffer L, Engleitner T, Ringshausen I, Nelson N, Jücker M, Wanninger S, Zenz T, Wendtner C, Manske K, Steiger K, Rad R, Müschen M, Ruland J, Buchner M. Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia. Nat Commun 2021;12:3526. [PMID: 34112805 DOI: 10.1038/s41467-021-23752-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Hua H, Zhang H, Chen J, Wang J, Liu J, Jiang Y. Targeting Akt in cancer for precision therapy. J Hematol Oncol 2021;14:128. [PMID: 34419139 DOI: 10.1186/s13045-021-01137-8] [Reference Citation Analysis]
21 Peng Q, Zhao P, Shen Y, Cheng M, Wu Y, Zhu Y. Prognostic implication and functional exploration for microRNA-20a as a molecular biomarker of gastrointestinal cancer. BMC Cancer 2020;20:420. [PMID: 32410584 DOI: 10.1186/s12885-020-06875-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Rickard BP, Conrad C, Sorrin AJ, Ruhi MK, Reader JC, Huang SA, Franco W, Scarcelli G, Polacheck WJ, Roque DM, Del Carmen MG, Huang HC, Demirci U, Rizvi I. Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response. Cancers (Basel) 2021;13:4318. [PMID: 34503128 DOI: 10.3390/cancers13174318] [Reference Citation Analysis]
23 Zhou Y, Men L, Sun Y, Wei M, Fan X. Pharmacodynamic effects and molecular mechanisms of lignans from Schisandra chinensis Turcz. (Baill.), a current review. Eur J Pharmacol 2021;892:173796. [PMID: 33345853 DOI: 10.1016/j.ejphar.2020.173796] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
24 Guo Y, Ning W, Jiang P, Lin S, Wang C, Tan X, Yao L, Peng D, Xue Y. GPS-PBS: A Deep Learning Framework to Predict Phosphorylation Sites that Specifically Interact with Phosphoprotein-Binding Domains. Cells 2020;9:E1266. [PMID: 32443803 DOI: 10.3390/cells9051266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
25 Wright SCE, Vasilevski N, Serra V, Rodon J, Eichhorn PJA. Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity. Cancers (Basel) 2021;13:1538. [PMID: 33810522 DOI: 10.3390/cancers13071538] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Wang Q, Geng W, Guo H, Wang Z, Xu K, Chen C, Wang S. Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer. J Hematol Oncol 2020;13:57. [PMID: 32429972 DOI: 10.1186/s13045-020-00895-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
27 Brown KA. Metabolic pathways in obesity-related breast cancer. Nat Rev Endocrinol 2021;17:350-63. [PMID: 33927368 DOI: 10.1038/s41574-021-00487-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Pan WW, Wubben TJ, Besirli CG. Photoreceptor metabolic reprogramming: current understanding and therapeutic implications. Commun Biol 2021;4:245. [PMID: 33627778 DOI: 10.1038/s42003-021-01765-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Choksey A, Timm KN. Cancer Therapy-Induced Cardiotoxicity-A Metabolic Perspective on Pathogenesis, Diagnosis and Therapy. Int J Mol Sci 2021;23:441. [PMID: 35008867 DOI: 10.3390/ijms23010441] [Reference Citation Analysis]
30 Bonelli M, Terenziani R, Zoppi S, Fumarola C, La Monica S, Cretella D, Alfieri R, Cavazzoni A, Digiacomo G, Galetti M, Petronini PG. Dual Inhibition of CDK4/6 and PI3K/AKT/mTOR Signaling Impairs Energy Metabolism in MPM Cancer Cells. Int J Mol Sci 2020;21:E5165. [PMID: 32708306 DOI: 10.3390/ijms21145165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 Tooley AS, Kazyken D, Bodur C, Gonzalez IE, Fingar DC. The innate immune kinase TBK1 directly increases mTORC2 activity and downstream signaling to Akt. J Biol Chem 2021;297:100942. [PMID: 34245780 DOI: 10.1016/j.jbc.2021.100942] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Ramachandran S, Srivastava SK. Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy. Mol Ther Oncolytics 2020;19:19-32. [PMID: 33024816 DOI: 10.1016/j.omto.2020.08.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Smith SF, Collins SE, Charest PG. Ras, PI3K and mTORC2 - three's a crowd? J Cell Sci 2020;133:jcs234930. [PMID: 33033115 DOI: 10.1242/jcs.234930] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
34 Shliapina V, Koriagina M, Vasilkova D, Govorun V, Dontsova O, Rubtsova M. Human Telomerase RNA Protein Encoded by Telomerase RNA is Involved in Metabolic Responses. Front Cell Dev Biol 2021;9:754611. [PMID: 34950657 DOI: 10.3389/fcell.2021.754611] [Reference Citation Analysis]
35 Khan K, Safi S, Abbas A, Badshah Y, Dilshad E, Rafiq M, Zahra K, Shabbir M. Unravelling Structure, Localization, and Genetic Crosstalk of KLF3 in Human Breast Cancer. Biomed Res Int 2020;2020:1354381. [PMID: 33490232 DOI: 10.1155/2020/1354381] [Reference Citation Analysis]
36 Cirone M. Cancer cells dysregulate PI3K/AKT/mTOR pathway activation to ensure their survival and proliferation: mimicking them is a smart strategy of gammaherpesviruses. Crit Rev Biochem Mol Biol 2021;:1-10. [PMID: 34130564 DOI: 10.1080/10409238.2021.1934811] [Reference Citation Analysis]
37 Kim J, Lee G. Metabolic Control of m6A RNA Modification. Metabolites 2021;11:80. [PMID: 33573224 DOI: 10.3390/metabo11020080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
38 Persico M, Abbruzzese C, Matteoni S, Matarrese P, Campana AM, Villani V, Pace A, Paggi MG. Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma. Cells 2022;11:263. [DOI: 10.3390/cells11020263] [Reference Citation Analysis]
39 Hoy AJ, Nagarajan SR, Butler LM. Tumour fatty acid metabolism in the context of therapy resistance and obesity. Nat Rev Cancer 2021. [PMID: 34417571 DOI: 10.1038/s41568-021-00388-4] [Reference Citation Analysis]
40 Zhang T, Gong Y, Meng H, Li C, Xue L. Symphony of epigenetic and metabolic regulation-interaction between the histone methyltransferase EZH2 and metabolism of tumor. Clin Epigenetics 2020;12:72. [PMID: 32448308 DOI: 10.1186/s13148-020-00862-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
41 Zhou L, Jiang Z, Gu J, Gu W, Han S. B7-H3 and digestive system cancers. Eur J Inflamm 2021;19:205873922110005. [DOI: 10.1177/20587392211000581] [Reference Citation Analysis]
42 Fukano M, Park M, Deblois G. Metabolic Flexibility Is a Determinant of Breast Cancer Heterogeneity and Progression. Cancers (Basel) 2021;13:4699. [PMID: 34572926 DOI: 10.3390/cancers13184699] [Reference Citation Analysis]
43 Chung CY, Singh K, Kotiadis VN, Valdebenito GE, Ahn JH, Topley E, Tan J, Andrews WD, Bilanges B, Pitceathly RDS, Szabadkai G, Yuneva M, Duchen MR. Constitutive activation of the PI3K-Akt-mTORC1 pathway sustains the m.3243 A > G mtDNA mutation. Nat Commun 2021;12:6409. [PMID: 34737295 DOI: 10.1038/s41467-021-26746-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Gkountakos A, Centonze G, Vita E, Belluomini L, Milella M, Bria E, Milione M, Scarpa A, Simbolo M. Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance. Biomedicines 2022;10:277. [DOI: 10.3390/biomedicines10020277] [Reference Citation Analysis]
45 Russi M, Marson D, Fermeglia A, Aulic S, Fermeglia M, Laurini E, Pricl S. The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer. Pharmacol Ther 2021;:108009. [PMID: 34619284 DOI: 10.1016/j.pharmthera.2021.108009] [Reference Citation Analysis]
46 Puccini J, Badgley MA, Bar-Sagi D. Exploiting cancer's drinking problem: regulation and therapeutic potential of macropinocytosis. Trends Cancer 2021:S2405-8033(21)00194-1. [PMID: 34649835 DOI: 10.1016/j.trecan.2021.09.004] [Reference Citation Analysis]
47 Montella L, Sarno F, Altucci L, Cioffi V, Sigona L, Di Colandrea S, De Simone S, Marinelli A, Facchini BA, De Vita F, Berretta M, de Falco R, Facchini G. A Root in Synapsis and the Other One in the Gut Microbiome-Brain Axis: Are the Two Poles of Ketogenic Diet Enough to Challenge Glioblastoma? Front Nutr 2021;8:703392. [PMID: 34422883 DOI: 10.3389/fnut.2021.703392] [Reference Citation Analysis]
48 Farhana A, Koh AE, Ling Mok P, Alsrhani A, Khan YS, Subbiah SK. Camptothecin Encapsulated in β-Cyclodextrin-EDTA-Fe3O4 Nanoparticles Induce Metabolic Reprogramming Repair in HT29 Cancer Cells through Epigenetic Modulation: A Bioinformatics Approach. Nanomaterials (Basel) 2021;11:3163. [PMID: 34947512 DOI: 10.3390/nano11123163] [Reference Citation Analysis]
49 Yang Q, Xu HR, Xiang SY, Zhang C, Ye Y, Shen CX, Mei HX, Zhang PH, Ma HY, Zheng SX, Smith FG, Jin SW, Wang Q. RCTR1 promotes alveolar fluid clearance by activating alveolar epithelial sodium channels and Na, K-ATPase in LPS-induced acute lung injury. J Pharmacol Exp Ther 2021:JPET-AR-2021-000712. [PMID: 34465632 DOI: 10.1124/jpet.121.000712] [Reference Citation Analysis]
50 Chang JG, Tien N, Chang YC, Lin ML, Chen SS. Oxidative Stress-Induced Unscheduled CDK1-Cyclin B1 Activity Impairs ER-Mitochondria-Mediated Bioenergetic Metabolism. Cells 2021;10:1280. [PMID: 34064109 DOI: 10.3390/cells10061280] [Reference Citation Analysis]
51 Wei Z, Liu X, Cheng C, Yu W, Yi P. Metabolism of Amino Acids in Cancer. Front Cell Dev Biol 2020;8:603837. [PMID: 33511116 DOI: 10.3389/fcell.2020.603837] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
52 Ohshima K, Morii E. Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis. Metabolites 2021;11:28. [PMID: 33401771 DOI: 10.3390/metabo11010028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
53 Schwarzmueller L, Bril O, Vermeulen L, Léveillé N. Emerging Role and Therapeutic Potential of lncRNAs in Colorectal Cancer. Cancers (Basel) 2020;12:E3843. [PMID: 33352769 DOI: 10.3390/cancers12123843] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
54 Parsons RB, Facey PD. Nicotinamide N-Methyltransferase: An Emerging Protagonist in Cancer Macro(r)evolution. Biomolecules 2021;11:1418. [PMID: 34680055 DOI: 10.3390/biom11101418] [Reference Citation Analysis]
55 Mehrpouri M, Pourbagheri-Sigaroodi A, Bashash D. The contributory roles of histone deacetylases (HDACs) in hematopoiesis regulation and possibilities for pharmacologic interventions in hematologic malignancies. Int Immunopharmacol 2021;100:108114. [PMID: 34492531 DOI: 10.1016/j.intimp.2021.108114] [Reference Citation Analysis]
56 Rather GM, Pramono AA, Szekely Z, Bertino JR, Tedeschi PM. In cancer, all roads lead to NADPH. Pharmacol Ther 2021;226:107864. [PMID: 33894275 DOI: 10.1016/j.pharmthera.2021.107864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Tan P, He L, Huang Y, Zhou Y. Optophysiology: Illuminating cell physiology with optogenetics. Physiol Rev 2022. [PMID: 35072525 DOI: 10.1152/physrev.00021.2021] [Reference Citation Analysis]
58 Mian AA, Zafar U, Ahmed SMA, Ottmann OG, Lalani EMA. Oncogene-independent resistance in Philadelphia chromosome - positive (Ph+) acute lymphoblastic leukemia (ALL) is mediated by activation of AKT/mTOR pathway. Neoplasia 2021;23:1016-27. [PMID: 34403880 DOI: 10.1016/j.neo.2021.07.009] [Reference Citation Analysis]
59 Rascio F, Spadaccino F, Rocchetti MT, Castellano G, Stallone G, Netti GS, Ranieri E. The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review. Cancers (Basel) 2021;13:3949. [PMID: 34439105 DOI: 10.3390/cancers13163949] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
60 Mata-martínez P, Bergón-gutiérrez M, del Fresno C. Dectin-1 Signaling Update: New Perspectives for Trained Immunity. Front Immunol 2022;13:812148. [DOI: 10.3389/fimmu.2022.812148] [Reference Citation Analysis]
61 Fan W, Shi R, Guan M, Chen P, Wu H, Su W, Wang Y, Li P. The Effects of Naringenin on miRNA-mRNA Profiles in HepaRG Cells. Int J Mol Sci 2021;22:2292. [PMID: 33669020 DOI: 10.3390/ijms22052292] [Reference Citation Analysis]
62 Scully T, Ettela A, LeRoith D, Gallagher EJ. Obesity, Type 2 Diabetes, and Cancer Risk. Front Oncol 2020;10:615375. [PMID: 33604295 DOI: 10.3389/fonc.2020.615375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Wang Z, Liu H, Hu Q, Shi L, Lü M, Deng M, Luo G. Cardamonin inhibits the progression of oesophageal cancer by inhibiting the PI3K/AKT signalling pathway. J Cancer 2021;12:3597-610. [PMID: 33995637 DOI: 10.7150/jca.55519] [Reference Citation Analysis]
64 Park SR, Kim SR, Hong IS, Lee HY. A Novel Therapeutic Approach for Colorectal Cancer Stem Cells: Blocking the PI3K/Akt Signaling Axis With Caffeic Acid. Front Cell Dev Biol 2020;8:585987. [PMID: 33425893 DOI: 10.3389/fcell.2020.585987] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
65 Patel KK, Sehgal VS, Kashfi K. Molecular targets of statins and their potential side effects: Not all the glitter is gold. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174906] [Reference Citation Analysis]
66 Tsegaye MA, He J, McGeehan K, Murphy IM, Nemera M, Schafer ZT. Oncogenic signaling inhibits c-FLIPL expression and its non-apoptotic function during ECM-detachment. Sci Rep 2021;11:18606. [PMID: 34545139 DOI: 10.1038/s41598-021-97715-4] [Reference Citation Analysis]
67 Gong TQ, Jiang YZ, Shao C, Peng WT, Liu MW, Li DQ, Zhang BY, Du P, Huang Y, Li FF, Li MY, Han ZL, Jin X, Ma D, Xiao Y, Yang PY, Qin J, Shao ZM, Zhu W. Proteome-centric cross-omics characterization and integrated network analyses of triple-negative breast cancer. Cell Rep 2022;38:110460. [PMID: 35235781 DOI: 10.1016/j.celrep.2022.110460] [Reference Citation Analysis]
68 Fang J, Wang J, Yu L, Xu W. Role of HOXC10 in Cancer. Front Oncol 2021;11:684021. [PMID: 34113572 DOI: 10.3389/fonc.2021.684021] [Reference Citation Analysis]
69 Tanhaye Kalate Sabz F, Amjadi FS, Zandieh Z, Hosseini E, Aflatoonian R, Tabatabaei M, Mohammadian M, Ashrafi M. GM-CSF (granulocyte-macrophage colony-stimulating factor) treatment improves sperm parameters in men with oligoasthenoteratospermia via PI3K/AKT pathway. Andrologia 2022;:e14427. [PMID: 35545511 DOI: 10.1111/and.14427] [Reference Citation Analysis]
70 Lim SA, Moon Y, Shin MH, Kim TJ, Chae S, Yee C, Hwang D, Park H, Lee KM. Hypoxia-Driven HIF-1α Activation Reprograms Pre-Activated NK Cells towards Highly Potent Effector Phenotypes via ERK/STAT3 Pathways. Cancers (Basel) 2021;13:1904. [PMID: 33920906 DOI: 10.3390/cancers13081904] [Reference Citation Analysis]
71 Schneider G, Wirth M, Keller U, Saur D. Rationale for MYC imaging and targeting in pancreatic cancer. EJNMMI Res 2021;11:104. [PMID: 34637026 DOI: 10.1186/s13550-021-00843-1] [Reference Citation Analysis]
72 de Jonge AV, Mutis T, Roemer MGM, Scheijen B, Chamuleau MED. Impact of MYC on Anti-Tumor Immune Responses in Aggressive B Cell Non-Hodgkin Lymphomas: Consequences for Cancer Immunotherapy. Cancers (Basel) 2020;12:E3052. [PMID: 33092116 DOI: 10.3390/cancers12103052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
73 Filić V, Mijanović L, Putar D, Talajić A, Ćetković H, Weber I. Regulation of the Actin Cytoskeleton via Rho GTPase Signalling in Dictyostelium and Mammalian Cells: A Parallel Slalom. Cells 2021;10:1592. [PMID: 34202767 DOI: 10.3390/cells10071592] [Reference Citation Analysis]
74 Gatti V, Bernassola F, Talora C, Melino G, Peschiaroli A. The Impact of the Ubiquitin System in the Pathogenesis of Squamous Cell Carcinomas. Cancers (Basel) 2020;12:E1595. [PMID: 32560247 DOI: 10.3390/cancers12061595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Deng Z, Yang Z, Peng J. Role of bioactive peptides derived from food proteins in programmed cell death to treat inflammatory diseases and cancer. Crit Rev Food Sci Nutr 2021;:1-19. [PMID: 34694177 DOI: 10.1080/10408398.2021.1992606] [Reference Citation Analysis]
76 Ehmsen JT, Höke A. Cellular and molecular features of neurogenic skeletal muscle atrophy. Exp Neurol 2020;331:113379. [PMID: 32533969 DOI: 10.1016/j.expneurol.2020.113379] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
77 Wu Y, Niu D, Deng S, Lei X, Xie Z, Yang X. Tumor-derived or non-tumor-derived exosomal noncodingRNAs and signaling pathways in tumor microenvironment. International Immunopharmacology 2022;106:108626. [DOI: 10.1016/j.intimp.2022.108626] [Reference Citation Analysis]
78 Yang T, Hu Y, Miao J, Chen J, Liu J, Cheng Y, Gao X. A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.009] [Reference Citation Analysis]
79 Wu L, Lin P, Zhao Y, Li X, Yang H, He Y. Prediction of Genetic Alterations in Oncogenic Signaling Pathways in Squamous Cell Carcinoma of the Head and Neck: Radiogenomic Analysis Based on Computed Tomography Images. J Comput Assist Tomogr 2021;45:932-40. [PMID: 34469904 DOI: 10.1097/RCT.0000000000001213] [Reference Citation Analysis]
80 Hon KW, Zainal Abidin SA, Othman I, Naidu R. The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer. Front Pharmacol 2021;12:768861. [PMID: 34887764 DOI: 10.3389/fphar.2021.768861] [Reference Citation Analysis]
81 Stulpinas A, Uzusienis T, Imbrasaite A, Krestnikova N, Unguryte A, Kalvelyte AV. Cell-cell and cell-substratum contacts in the regulation of MAPK and Akt signalling: Importance in therapy, biopharmacy and bioproduction. Cell Signal 2021;84:110034. [PMID: 33933583 DOI: 10.1016/j.cellsig.2021.110034] [Reference Citation Analysis]
82 Wang T, Zhang Y, He Y, Liu Y, Qi P. Screening and Bioinformatics Analysis of Competitive Endogenous RNA Regulatory Network --Related to Circular RNA in Breast Cancer. Biomed Res Int 2021;2021:5575286. [PMID: 34545330 DOI: 10.1155/2021/5575286] [Reference Citation Analysis]
83 Goncalves MD, Farooki A. Management of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia. Integr Cancer Ther 2022;21:15347354211073163. [PMID: 35075945 DOI: 10.1177/15347354211073163] [Reference Citation Analysis]
84 Takahashi H, Rokudai S, Kawabata-Iwakawa R, Sakakura K, Oyama T, Nishiyama M, Chikamatsu K. AKT3 is a key regulator of head and neck squamous cell carcinoma. Cancer Sci 2021;112:2325-34. [PMID: 33811778 DOI: 10.1111/cas.14911] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Ferreira LP, Gaspar VM, Mendes L, Duarte IF, Mano JF. Organotypic 3D decellularized matrix tumor spheroids for high-throughput drug screening. Biomaterials 2021;275:120983. [PMID: 34186236 DOI: 10.1016/j.biomaterials.2021.120983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Kondo H, Ratcliffe CDH, Hooper S, Ellis J, MacRae JI, Hennequart M, Dunsby CW, Anderson KI, Sahai E. Single-cell resolved imaging reveals intra-tumor heterogeneity in glycolysis, transitions between metabolic states, and their regulatory mechanisms. Cell Rep 2021;34:108750. [PMID: 33596424 DOI: 10.1016/j.celrep.2021.108750] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
87 Zhu Y, Liu Z, Lv D, Cheng X, Wang J, Liu B, Han Z, Wang Y, Liu R, Gao Y. Identification of PYGL as a key prognostic gene of glioma by integrated bioinformatics analysis. Future Oncol 2022. [PMID: 35037470 DOI: 10.2217/fon-2021-0759] [Reference Citation Analysis]
88 Wai Hon K, Zainal Abidin SA, Othman I, Naidu R. Insights into the Role of microRNAs in Colorectal Cancer (CRC) Metabolism. Cancers (Basel) 2020;12:E2462. [PMID: 32878019 DOI: 10.3390/cancers12092462] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
89 Rehbein U, Prentzell MT, Cadena Sandoval M, Heberle AM, Henske EP, Opitz CA, Thedieck K. The TSC Complex-mTORC1 Axis: From Lysosomes to Stress Granules and Back. Front Cell Dev Biol 2021;9:751892. [PMID: 34778262 DOI: 10.3389/fcell.2021.751892] [Reference Citation Analysis]
90 Michel L, Totzeck M, Rassaf T. Cardiac dysfunction from cancer and cancer therapy: new pathways for the prevention of late cardiotoxicity. Basic Res Cardiol 2021;116:62. [PMID: 34671866 DOI: 10.1007/s00395-021-00903-6] [Reference Citation Analysis]
91 Koch PA, Dornan GL, Hessenberger M, Haucke V. The molecular mechanisms mediating class II PI 3-kinase function in cell physiology. FEBS J 2021. [PMID: 33387369 DOI: 10.1111/febs.15692] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
92 Gu Y, Wu X, Zhang J, Fang Y, Pan Y, Shu Y, Ma P. The evolving landscape of N6-methyladenosine modification in the tumor microenvironment. Mol Ther 2021;29:1703-15. [PMID: 33839323 DOI: 10.1016/j.ymthe.2021.04.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
93 Chen R, Sun G, Xu L, Zhang X, Zeng W, Sun X. Didymin attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress. Chinese Herbal Medicines 2021. [DOI: 10.1016/j.chmed.2021.07.002] [Reference Citation Analysis]
94 Maravat M, Bertrand M, Landon C, Fayon F, Morisset-Lopez S, Sarou-Kanian V, Decoville M. Complementary Nuclear Magnetic Resonance-Based Metabolomics Approaches for Glioma Biomarker Identification in a Drosophila melanogaster Model. J Proteome Res 2021;20:3977-91. [PMID: 34286978 DOI: 10.1021/acs.jproteome.1c00304] [Reference Citation Analysis]
95 Tao S, Li X, Wei W, Wei Z, Zhang C, Wang F, Dawes H, Guo S. Polymeric coating on β-TCP scaffolds provides immobilization of small extracellular vesicles with surface-functionalization and ZEB1-Loading for bone defect repair in diabetes mellitus. Biomaterials 2022;283:121465. [DOI: 10.1016/j.biomaterials.2022.121465] [Reference Citation Analysis]
96 Altuna-Coy A, Ruiz-Plazas X, Alves-Santiago M, Segarra-Tomás J, Chacón MR. Serum Levels of the Cytokine TWEAK Are Associated with Metabolic Status in Patients with Prostate Cancer and Modulate Cancer Cell Lipid Metabolism In Vitro. Cancers (Basel) 2021;13:4688. [PMID: 34572917 DOI: 10.3390/cancers13184688] [Reference Citation Analysis]
97 Sun Y, Ye C, Tian W, Ye W, Gao YY, Feng YD, Zhang HN, Ma GY, Wang SJ, Cao W, Li XQ. TRPC1 promotes the genesis and progression of colorectal cancer via activating CaM-mediated PI3K/AKT signaling axis. Oncogenesis 2021;10:67. [PMID: 34642309 DOI: 10.1038/s41389-021-00356-5] [Reference Citation Analysis]
98 Vasan N, Cantley LC. At a crossroads: how to translate the roles of PI3K in oncogenic and metabolic signalling into improvements in cancer therapy. Nat Rev Clin Oncol 2022. [PMID: 35484287 DOI: 10.1038/s41571-022-00633-1] [Reference Citation Analysis]
99 Lv J, Zhang S, Liu Y, Li C, Guo T, Zhang S, Li Z, Jiao Z, Sun H, Zhang Y, Xu L. NR2F1-AS1/miR-190a/PHLDB2 Induces the Epithelial-Mesenchymal Transformation Process in Gastric Cancer by Promoting Phosphorylation of AKT3. Front Cell Dev Biol 2021;9:688949. [PMID: 34746118 DOI: 10.3389/fcell.2021.688949] [Reference Citation Analysis]
100 Li Y, Dong R, Lu M, Cheng C, Feng Z, Zhao R, Liang J, Han J, Jiang J, Xu-Welliver M, Renaud S, Tian H. Let-7b-3p inhibits tumor growth and metastasis by targeting the BRF2-mediated MAPK/ERK pathway in human lung adenocarcinoma. Transl Lung Cancer Res 2021;10:1841-56. [PMID: 34012797 DOI: 10.21037/tlcr-21-299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Liu Y, Zhang M, He T, Yang W, Wang L, Zhang L, Guo M. Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling. Clin Epigenetics 2020;12:22. [PMID: 32041673 DOI: 10.1186/s13148-020-0815-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
102 Feng Y, Zhao Y, Li Y, Peng T, Kuang Y, Shi X, Wang G, Peng F, Yu C. Inhibition of Fibroblast Activation in Uterine Leiomyoma by Components of Rhizoma Curcumae and Rhizoma Sparganii. Front Public Health 2021;9:650022. [PMID: 33732680 DOI: 10.3389/fpubh.2021.650022] [Reference Citation Analysis]
103 Claridge SE, Hopkins BD. Circling back to PTEN: Fumarate inhibits canonical tumor suppressor. Mol Cell 2022;82:1244-5. [PMID: 35395197 DOI: 10.1016/j.molcel.2022.03.013] [Reference Citation Analysis]
104 Mery B, Poulard C, Le Romancer M, Trédan O. Targeting AKT in ER-Positive HER2-Negative Metastatic Breast Cancer: From Molecular Promises to Real Life Pitfalls? Int J Mol Sci 2021;22:13512. [PMID: 34948307 DOI: 10.3390/ijms222413512] [Reference Citation Analysis]
105 Petroni G, Cantley LC, Santambrogio L, Formenti SC, Galluzzi L. Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. Nat Rev Clin Oncol 2021. [PMID: 34819622 DOI: 10.1038/s41571-021-00579-w] [Reference Citation Analysis]
106 Parekh U, McDonald D, Dailamy A, Wu Y, Cordes T, Zhang K, Tipps A, Metallo C, Mali P. Charting oncogenicity of genes and variants across lineages via multiplexed screens in teratomas. iScience 2021;24:103149. [PMID: 34646987 DOI: 10.1016/j.isci.2021.103149] [Reference Citation Analysis]
107 Heberle AM, Rehbein U, Rodríguez Peiris M, Thedieck K. Finding new edges: systems approaches to MTOR signaling. Biochem Soc Trans 2021;49:41-54. [PMID: 33544134 DOI: 10.1042/BST20190730] [Reference Citation Analysis]
108 Torres M, Rosselló CA, Fernández-García P, Lladó V, Kakhlon O, Escribá PV. The Implications for Cells of the Lipid Switches Driven by Protein-Membrane Interactions and the Development of Membrane Lipid Therapy. Int J Mol Sci 2020;21:E2322. [PMID: 32230887 DOI: 10.3390/ijms21072322] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
109 Fouad S, Hauton D, D'Angiolella V. E2F1: Cause and Consequence of DNA Replication Stress. Front Mol Biosci 2020;7:599332. [PMID: 33665206 DOI: 10.3389/fmolb.2020.599332] [Reference Citation Analysis]
110 Han S, Jung M, Kim AS, Lee DY, Cha BH, Putnam CW, Lim KS, Bull DA, Won YW. Peptide Adjuvant to Invigorate Cytolytic Activity of NK Cells in an Obese Mouse Cancer Model. Pharmaceutics 2021;13:1279. [PMID: 34452238 DOI: 10.3390/pharmaceutics13081279] [Reference Citation Analysis]
111 Tran AQ, Sullivan SA, Chan LL, Yin Y, Sun W, Fang Z, Dugar S, Zhou C, Bae-Jump V. SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer. Front Oncol 2020;10:624498. [PMID: 33659215 DOI: 10.3389/fonc.2020.624498] [Reference Citation Analysis]
112 Liu Y, Yang S, Wang F, Zhou Z, Xu W, Xie J, Qiao L, Gu Y. PLEK2 promotes osteosarcoma tumorigenesis and metastasis by activating the PI3K/AKT signaling pathway. Oncol Lett 2021;22:534. [PMID: 34084215 DOI: 10.3892/ol.2021.12795] [Reference Citation Analysis]
113 Jia H, Ma T, Jia S, Ouyang Y. AKT3 and related molecules as potential biomarkers responsible for cryptorchidism and cryptorchidism-induced azoospermia. Transl Pediatr 2021;10:1805-17. [PMID: 34430428 DOI: 10.21037/tp-21-31] [Reference Citation Analysis]
114 Gong W, Chen X, Shi T, Shao X, An X, Qin J, Chen X, Jiang Q, Guo B. Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation. Front Pharmacol 2021;12:727808. [PMID: 34658868 DOI: 10.3389/fphar.2021.727808] [Reference Citation Analysis]
115 Clayton NS, Fox M, Vicenté-Garcia JJ, Schroeder CM, Littlewood TD, Wilde JI, Krishnan K, Brown MJB, Crafter C, Mott HR, Owen D. Assembly of nuclear dimers of PI3K regulatory subunits is regulated by the Cdc42-activated tyrosine kinase ACK. J Biol Chem 2022;:101916. [PMID: 35429500 DOI: 10.1016/j.jbc.2022.101916] [Reference Citation Analysis]
116 Mou K, Zhang J, Mu X, Wang L, Liu W, Ge R. Zwint facilitates melanoma progression by promoting c-Myc expression. Exp Ther Med 2021;22:818. [PMID: 34131441 DOI: 10.3892/etm.2021.10250] [Reference Citation Analysis]
117 Götting I, Jendrossek V, Matschke J. A New Twist in Protein Kinase B/Akt Signaling: Role of Altered Cancer Cell Metabolism in Akt-Mediated Therapy Resistance. Int J Mol Sci 2020;21:E8563. [PMID: 33202866 DOI: 10.3390/ijms21228563] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
118 Loissell-Baltazar YA, Dokudovskaya S. SEA and GATOR 10 Years Later. Cells 2021;10:2689. [PMID: 34685669 DOI: 10.3390/cells10102689] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Lin B, Dong X, Wang Q, Li W, Zhu M, Li M. AFP-Inhibiting Fragments for Drug Delivery: The Promise and Challenges of Targeting Therapeutics to Cancers. Front Cell Dev Biol 2021;9:635476. [PMID: 33898423 DOI: 10.3389/fcell.2021.635476] [Reference Citation Analysis]
120 Chowjarean V, Sadabpod K. Antiproliferative Effect of Grammatophyllum speciosum Ethanolic Extract and Its Bioactive Compound on Human Breast Cancer Cells. ScientificWorldJournal 2021;2021:3752169. [PMID: 34646091 DOI: 10.1155/2021/3752169] [Reference Citation Analysis]
121 Li Y, Zhao X, Sun M, Pei D, Li A. Deciphering the Epigenetic Code of Stem Cells Derived From Dental Tissues. Front Dent Med 2022;2:807046. [DOI: 10.3389/fdmed.2021.807046] [Reference Citation Analysis]
122 Akbay B, Germini D, Bissenbaev AK, Musinova YR, Sheval EV, Vassetzky Y, Dokudovskaya S. HIV-1 Tat Activates Akt/mTORC1 Pathway and AICDA Expression by Downregulating Its Transcriptional Inhibitors in B Cells. Int J Mol Sci 2021;22:1588. [PMID: 33557396 DOI: 10.3390/ijms22041588] [Reference Citation Analysis]
123 Torres-Velarde JM, Kolora SRR, Khudyakov JI, Crocker DE, Sudmant PH, Vázquez-Medina JP. Elephant seal muscle cells adapt to sustained glucocorticoid exposure by shifting their metabolic phenotype. Am J Physiol Regul Integr Comp Physiol 2021;321:R413-28. [PMID: 34260302 DOI: 10.1152/ajpregu.00052.2021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Yoshida K, Yamamoto Y, Ochiya T. miRNA signaling networks in cancer stem cells. Regen Ther 2021;17:1-7. [PMID: 33598508 DOI: 10.1016/j.reth.2021.01.004] [Reference Citation Analysis]
125 Chen S, Bie M, Wang X, Fan M, Chen B, Shi Q, Jiang Y. PGRN exacerbates the progression of non-small cell lung cancer via PI3K/AKT/Bcl-2 antiapoptotic signaling. Genes & Diseases 2021. [DOI: 10.1016/j.gendis.2021.05.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Soriano O, Alcón-Pérez M, Vicente-Manzanares M, Castellano E. The Crossroads between RAS and RHO Signaling Pathways in Cellular Transformation, Motility and Contraction. Genes (Basel) 2021;12:819. [PMID: 34071831 DOI: 10.3390/genes12060819] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Pan S, Liang S, Wang X. ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling. Life Sci 2021;278:119581. [PMID: 33961854 DOI: 10.1016/j.lfs.2021.119581] [Reference Citation Analysis]
128 Brockmueller A, Sameri S, Liskova A, Zhai K, Varghese E, Samuel SM, Büsselberg D, Kubatka P, Shakibaei M. Resveratrol's Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism. Cancers (Basel) 2021;13:E188. [PMID: 33430318 DOI: 10.3390/cancers13020188] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
129 Xie J, Liang T, Zhao J, Xu Z, Tian P, Wang R, Mi C, Huang W, Chen W, Zhang H. Lnc-HZ08 regulates BPDE-induced trophoblast cell dysfunctions by promoting PI3K ubiquitin degradation and is associated with miscarriage. Cell Biol Toxicol 2021. [PMID: 33864160 DOI: 10.1007/s10565-021-09606-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
130 Roskoski R Jr. Blockade of mutant RAS oncogenic signaling with a special emphasis on KRAS. Pharmacol Res 2021;172:105806. [PMID: 34450320 DOI: 10.1016/j.phrs.2021.105806] [Reference Citation Analysis]
131 Qiao Q, Bai R, Song W, Gao H, Zhang M, Lu J, Hong M, Zhang X, Sun P, Zhang Q, Zhao P. Human α-defensin 5 suppressed colon cancer growth by targeting PI3K pathway. Exp Cell Res 2021;407:112809. [PMID: 34487729 DOI: 10.1016/j.yexcr.2021.112809] [Reference Citation Analysis]
132 Baraniya D, Chitrala KN, Al-hebshi NN. Global transcriptional response of oral squamous cell carcinoma cell lines to health-associated oral bacteria - an in vitro study. Journal of Oral Microbiology 2022;14:2073866. [DOI: 10.1080/20002297.2022.2073866] [Reference Citation Analysis]
133 Minciacchi VR, Kumar R, Krause DS. Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future. Cells 2021;10:117. [PMID: 33435150 DOI: 10.3390/cells10010117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
134 Vaidyanathan S, Salmi TM, Sathiqu RM, McConville MJ, Cox AG, Brown KK. YAP regulates an SGK1/mTORC1/SREBP-dependent lipogenic program to support proliferation and tissue growth. Dev Cell 2022:S1534-5807(22)00070-3. [PMID: 35216681 DOI: 10.1016/j.devcel.2022.02.004] [Reference Citation Analysis]
135 Kappes L, Amer RL, Sommerlatte S, Bashir G, Plattfaut C, Gieseler F, Gemoll T, Busch H, Altahrawi A, Al-Sbiei A, Haneefa SM, Arafat K, Schimke LF, Khawanky NE, Schulze-Forster K, Heidecke H, Kerstein-Staehle A, Marschner G, Pitann S, Ochs HD, Mueller A, Attoub S, Fernandez-Cabezudo MJ, Riemekasten G, Al-Ramadi BK, Cabral-Marques O. Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis. Sci Rep 2020;10:15931. [PMID: 32985601 DOI: 10.1038/s41598-020-72960-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
136 Coleman MF, Cozzo AJ, Pfeil AJ, Etigunta SK, Hursting SD. Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy. Cancers (Basel) 2020;12:E852. [PMID: 32244756 DOI: 10.3390/cancers12040852] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
137 Zhang X, Zhu X, Zhong Z, Du J, Fang G, Cui X, Guan L, Hu Y, Wang H, Zhang P. Small Molecule‐Induced Differentiation As a Potential Therapy for Liver Cancer. Advanced Science. [DOI: 10.1002/advs.202103619] [Reference Citation Analysis]
138 Huang A, Zeng P, Li Y, Lu W, Lai Y. LY294002 Is a Promising Inhibitor to Overcome Sorafenib Resistance in FLT3-ITD Mutant AML Cells by Interfering With PI3K/Akt Signaling Pathway. Front Oncol 2021;11:782065. [PMID: 34820336 DOI: 10.3389/fonc.2021.782065] [Reference Citation Analysis]
139 Gu YF, Ge XP. UBR5 inhibits the radiosensitivity of non-small cell lung cancer cells via the activation of the PI3K/AKT pathway. J Investig Med 2021;69:970-5. [PMID: 33811132 DOI: 10.1136/jim-2020-001736] [Reference Citation Analysis]
140 Kolios AGA, Tsokos GC, Klatzmann D. Interleukin-2 and regulatory T cells in rheumatic diseases. Nat Rev Rheumatol 2021;17:749-66. [PMID: 34728817 DOI: 10.1038/s41584-021-00707-x] [Reference Citation Analysis]
141 Scheiter A, Evert K, Reibenspies L, Cigliano A, Annweiler K, Müller K, Pöhmerer LM, Xu H, Cui G, Itzel T, Materna-Reichelt S, Coluccio A, Honarnejad K, Teufel A, Brochhausen C, Dombrowski F, Chen X, Evert M, Calvisi DF, Utpatel K. RASSF1A independence and early galectin-1 upregulation in PIK3CA-induced hepatocarcinogenesis: new therapeutic venues. Mol Oncol 2021. [PMID: 34748271 DOI: 10.1002/1878-0261.13135] [Reference Citation Analysis]
142 Zhang BH, Liu H, Yuan Y, Weng XD, Du Y, Chen H, Chen ZY, Wang L, Liu XH. Knockdown of TRIM8 Protects HK-2 Cells Against Hypoxia/Reoxygenation-Induced Injury by Inhibiting Oxidative Stress-Mediated Apoptosis and Pyroptosis via PI3K/Akt Signal Pathway. Drug Des Devel Ther 2021;15:4973-83. [PMID: 34916780 DOI: 10.2147/DDDT.S333372] [Reference Citation Analysis]
143 Wang W, Sindrewicz-Goral P, Chen C, Duckworth CA, Pritchard DM, Rhodes JM, Yu LG. Appearance of peanut agglutinin in the blood circulation after peanut ingestion promotes endothelial secretion of metastasis-promoting cytokines. Carcinogenesis 2021:bgab059. [PMID: 34223877 DOI: 10.1093/carcin/bgab059] [Reference Citation Analysis]
144 Shibuya CM, Tjioe KC, Oliveira SHP, Bernabé DG. Propranolol inhibits cell viability and expression of the pro-tumorigenic proteins Akt, NF-ĸB, and VEGF in oral squamous cell carcinoma. Archives of Oral Biology 2022. [DOI: 10.1016/j.archoralbio.2022.105383] [Reference Citation Analysis]
145 Spaan I, Timmerman LM, Kimman T, Slomp A, Cuenca M, van Nieuwenhuijzen N, Moesbergen LM, Minnema MC, Raymakers RA, Peperzak V. Direct P70S6K1 inhibition to replace dexamethasone in synergistic combination with MCL-1 inhibition in multiple myeloma. Blood Adv 2021;5:2593-607. [PMID: 34152396 DOI: 10.1182/bloodadvances.2020003624] [Reference Citation Analysis]
146 Wang S, Cai J, Zhang S, Dong M, Zhang L, Xu Y, Shen B, Chen S. Loss of polarity protein Par3, via transcription factor Snail, promotes bladder cancer metastasis. Cancer Sci 2021;112:2625-41. [PMID: 33931921 DOI: 10.1111/cas.14920] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
147 Shin N, Lee HJ, Sim DY, Im E, Park JE, Park WY, Cho AR, Shim BS, Kim SH. Apoptotic effect of compound K in hepatocellular carcinoma cells via inhibition of glycolysis and Akt/mTOR/c-Myc signaling. Phytother Res 2021;35:3812-20. [PMID: 33856720 DOI: 10.1002/ptr.7087] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
148 Wang W, Yang Z, Li A, Liu Q, Sun Y, Gu W. Design, synthesis, anticancer activity and mechanism studies of novel 2-amino-4-aryl-pyrimidine derivatives of ursolic acid. New J Chem . [DOI: 10.1039/d1nj05294b] [Reference Citation Analysis]
149 Zhang Y, Li Y, Wang Q, Su B, Xu H, Sun Y, Sun P, Li R, Peng X, Cai J. Role of RASA1 in cancer: A review and update (Review). Oncol Rep 2020;44:2386-96. [PMID: 33125148 DOI: 10.3892/or.2020.7807] [Reference Citation Analysis]
150 Grega T, Vojtechova G, Gregova M, Zavoral M, Suchanek S. Pathophysiological Characteristics Linking Type 2 Diabetes Mellitus and Colorectal Neoplasia. Physiol Res 2021;70:509-22. [PMID: 34062073 DOI: 10.33549/physiolres.934631] [Reference Citation Analysis]
151 Miao K, Pan T, Mou Y, Zhang L, Xiong W, Xu Y, Yu J, Wang Y. Scutellarein inhibits BLM-mediated pulmonary fibrosis by affecting fibroblast differentiation, proliferation, and apoptosis. Ther Adv Chronic Dis 2020;11:2040622320940185. [PMID: 32843954 DOI: 10.1177/2040622320940185] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
152 Bannoura SF, Uddin MH, Nagasaka M, Fazili F, Al-Hallak MN, Philip PA, El-Rayes B, Azmi AS. Targeting KRAS in pancreatic cancer: new drugs on the horizon. Cancer Metastasis Rev 2021;40:819-35. [PMID: 34499267 DOI: 10.1007/s10555-021-09990-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 Dai F, Zhang QB, Tang YP, He YX, Yi T, Qing YF. Expression Profile and Potential Function of Circular RNAs in Peripheral Blood Mononuclear Cells in Male Patients With Primary Gout. Front Genet 2021;12:728091. [PMID: 34764979 DOI: 10.3389/fgene.2021.728091] [Reference Citation Analysis]
154 Dong S, Liang S, Cheng Z, Zhang X, Luo L, Li L, Zhang W, Li S, Xu Q, Zhong M, Zhu J, Zhang G, Hu S. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer. J Exp Clin Cancer Res 2022;41:15. [PMID: 34998404 DOI: 10.1186/s13046-021-02229-6] [Reference Citation Analysis]
155 Yan L, Tu B, Yao J, Gong J, Carugo A, Bristow CA, Wang Q, Zhu C, Dai B, Kang Y, Han L, Feng N, Jin Y, Fleming J, Heffernan TP, Yao W, Ying H. Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition. Cancer Res 2021;81:4054-65. [PMID: 34117030 DOI: 10.1158/0008-5472.CAN-20-3792] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
156 Ge X, Li M, Yin J, Shi Z, Fu Y, Zhao N, Chen H, Meng L, Li X, Hu Z, Zhao X, Guo H, Qian X. Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma. Mol Cell 2022:S1097-2765(22)00105-8. [PMID: 35216667 DOI: 10.1016/j.molcel.2022.01.029] [Reference Citation Analysis]
157 Wu CW, Wang SG, Lee CH, Chan WL, Lin ML, Chen SS. Enforced C-Src Activation Causes Compartmental Dysregulation of PI3K and PTEN Molecules in Lipid Rafts of Tongue Squamous Carcinoma Cells by Attenuating Rac1-Akt-GLUT-1-Mediated Sphingolipid Synthesis. Int J Mol Sci 2020;21:E5812. [PMID: 32823607 DOI: 10.3390/ijms21165812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
158 Pietras P, Leśniczak-Staszak M, Kasprzak A, Andrzejewska M, Jopek K, Sowiński M, Rucinski M, Lyons SM, Ivanov P, Szaflarski W. MVP Expression Facilitates Tumor Cell Proliferation and Migration Supporting the Metastasis of Colorectal Cancer Cells. Int J Mol Sci 2021;22:12121. [PMID: 34829999 DOI: 10.3390/ijms222212121] [Reference Citation Analysis]
159 Lu X, Yang C, Hu Y, Xu J, Shi C, Rao J, Yu W, Cheng F. Upregulation of miR-1254 promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion via Inactivation of the Hippo-YAP signaling pathway by decreasing PAX5. J Cancer 2021;12:771-89. [PMID: 33403035 DOI: 10.7150/jca.49680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
160 Grillo E, Corsini M, Ravelli C, Zammataro L, Bacci M, Morandi A, Monti E, Presta M, Mitola S. Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence. Cancer Lett 2021;507:80-8. [PMID: 33744390 DOI: 10.1016/j.canlet.2021.03.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
161 Liang J, Sun W, Song H, Wang C, Li Q, Li C, Wei D, Zhao Y, Li C, Zhang H. NOL6 promotes the proliferation and migration of endometrial cancer cells by regulating TWIST1 expression. Epigenomics 2021;13:1571-85. [PMID: 34607487 DOI: 10.2217/epi-2021-0218] [Reference Citation Analysis]
162 Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond) 2021;41:109-20. [PMID: 33119215 DOI: 10.1002/cac2.12108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
163 Harjes U. Metabolites going up in smoke. Nat Rev Cancer 2020;20:482. [PMID: 32636490 DOI: 10.1038/s41568-020-0289-3] [Reference Citation Analysis]
164 Davidson CD, Gillis NE, Carr FE. Thyroid Hormone Receptor Beta as Tumor Suppressor: Untapped Potential in Treatment and Diagnostics in Solid Tumors. Cancers (Basel) 2021;13:4254. [PMID: 34503062 DOI: 10.3390/cancers13174254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Tarragó-Celada J, Cascante M. Targeting the Metabolic Adaptation of Metastatic Cancer. Cancers (Basel) 2021;13:1641. [PMID: 33915900 DOI: 10.3390/cancers13071641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
166 Pasquale V, Ducci G, Campioni G, Ventrici A, Assalini C, Busti S, Vanoni M, Vago R, Sacco E. Profiling and Targeting of Energy and Redox Metabolism in Grade 2 Bladder Cancer Cells with Different Invasiveness Properties. Cells 2020;9:E2669. [PMID: 33322565 DOI: 10.3390/cells9122669] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
167 Zhang X, Kan H, Liu Y, Ding W. Plumbagin induces Ishikawa cell cycle arrest, autophagy, and apoptosis via the PI3K/Akt signaling pathway in endometrial cancer. Food and Chemical Toxicology 2021;148:111957. [DOI: 10.1016/j.fct.2020.111957] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
168 Tan R, Zhang G, Liu R, Hou J, Dong Z, Deng C, Wan S, Lai X, Cui H. Identification of Early Diagnostic and Prognostic Biomarkers via WGCNA in Stomach Adenocarcinoma. Front Oncol 2021;11:636461. [PMID: 34221961 DOI: 10.3389/fonc.2021.636461] [Reference Citation Analysis]
169 Chan S, Smith E, Gao Y, Kwan J, Blum BC, Tilston-Lunel AM, Turcinovic I, Varelas X, Cardamone MD, Monti S, Emili A, Perissi V. Loss of G-Protein Pathway Suppressor 2 Promotes Tumor Growth Through Activation of AKT Signaling. Front Cell Dev Biol 2020;8:608044. [PMID: 33490071 DOI: 10.3389/fcell.2020.608044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
170 Nuvoli B, Antoniani B, Libener R, Maconi A, Sacconi A, Carosi M, Galati R. Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities. J Exp Clin Cancer Res 2021;40:257. [PMID: 34404424 DOI: 10.1186/s13046-021-02050-1] [Reference Citation Analysis]
171 Guak H, Krawczyk CM. Implications of cellular metabolism for immune cell migration. Immunology 2020;161:200-8. [PMID: 32920838 DOI: 10.1111/imm.13260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
172 Case KC, Schmidtke MW, Greenberg ML. The paradoxical role of inositol in cancer: a consequence of the metabolic state of a tumor. Cancer Metastasis Rev. [DOI: 10.1007/s10555-022-10032-8] [Reference Citation Analysis]
173 Yu G, Li S, Wei R, Jiang Z, Chiefari E. Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications. Journal of Diabetes Research 2022;2022:1-16. [DOI: 10.1155/2022/1747326] [Reference Citation Analysis]
174 Chowdhury P, Perera D, Powell RT, Talley T, Tripathi DN, Park YS, Mancini MA, Davies P, Stephan C, Coarfa C, Dere R. Therapeutically actionable signaling node to rescue AURKA driven loss of primary cilia in VHL-deficient cells. Sci Rep 2021;11:10461. [PMID: 34002003 DOI: 10.1038/s41598-021-89933-7] [Reference Citation Analysis]
175 Encarnación-Rosado J, Kimmelman AC. Harnessing metabolic dependencies in pancreatic cancers. Nat Rev Gastroenterol Hepatol 2021;18:482-92. [PMID: 33742165 DOI: 10.1038/s41575-021-00431-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
176 Dinoi G, Mariani A, Martinelli E, Ciucci A, Zannoni GF, Weaver AL, Keeney GL, Vasmatzis G, Anastasiadis PZ, Fanfani F, Scambia G, Gallo D. In search for biomarkers and potential drug targets for uterine serous endometrial cancer. J Cancer Res Clin Oncol 2021;147:1647-58. [PMID: 33754208 DOI: 10.1007/s00432-021-03566-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
177 Chedere A, Hari K, Kumar S, Rangarajan A, Jolly MK. Multi-Stability and Consequent Phenotypic Plasticity in AMPK-Akt Double Negative Feedback Loop in Cancer Cells. J Clin Med 2021;10:472. [PMID: 33530625 DOI: 10.3390/jcm10030472] [Reference Citation Analysis]
178 Noguchi M, Hirata N, Tanaka T, Suizu F, Nakajima H, Chiorini JA. Autophagy as a modulator of cell death machinery. Cell Death Dis 2020;11:517. [PMID: 32641772 DOI: 10.1038/s41419-020-2724-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
179 Ala M, Ala M. Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next? ACS Pharmacol Transl Sci 2021;4:1747-70. [PMID: 34927008 DOI: 10.1021/acsptsci.1c00167] [Reference Citation Analysis]
180 Zhao M, Feng J, Tang L. Competing endogenous RNAs in lung cancer. Cancer Biol Med 2021;18:1-20. [PMID: 33628581 DOI: 10.20892/j.issn.2095-3941.2020.0203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
181 Helou DG, Shafiei-Jahani P, Hurrell BP, Painter JD, Quach C, Howard E, Akbari O. LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity. J Allergy Clin Immunol 2021:S0091-6749(21)00936-2. [PMID: 34144112 DOI: 10.1016/j.jaci.2021.05.042] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
182 Zhang K, Ji M, Lin S, Peng S, Zhang Z, Zhang M, Zhang J, Zhang Y, Wu D, Tian H, Chen X, Xu H. Design, Synthesis, and Biological Evaluation of a Novel Photocaged PI3K Inhibitor toward Precise Cancer Treatment. J Med Chem 2021;64:7331-40. [PMID: 33876637 DOI: 10.1021/acs.jmedchem.0c02186] [Reference Citation Analysis]
183 Wu X, Sakharkar MK, Wabitsch M, Yang J. Effects of Sphingosine-1-Phosphate on Cell Viability, Differentiation, and Gene Expression of Adipocytes. Int J Mol Sci 2020;21:E9284. [PMID: 33291440 DOI: 10.3390/ijms21239284] [Reference Citation Analysis]
184 Yang R, Yi M, Xiang B. Novel Insights on Lipid Metabolism Alterations in Drug Resistance in Cancer. Front Cell Dev Biol 2022;10:875318. [DOI: 10.3389/fcell.2022.875318] [Reference Citation Analysis]
185 Chen Q, Li L, Liu X, Feng Q, Zhang Y, Zheng P, Cui N. Hexokinases 2 promoted cell motility and distant metastasis by elevating fibronectin through Akt1/p-Akt1 in cervical cancer cells. Cancer Cell Int 2021;21:600. [PMID: 34758823 DOI: 10.1186/s12935-021-02312-0] [Reference Citation Analysis]
186 Wang R, Tang Q. Current Advances on the Important Roles of Enhancer RNAs in Molecular Pathways of Cancer. Int J Mol Sci 2021;22:5640. [PMID: 34073237 DOI: 10.3390/ijms22115640] [Reference Citation Analysis]
187 He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B. Targeting PI3K/Akt signal transduction for cancer therapy. Sig Transduct Target Ther 2021;6. [DOI: 10.1038/s41392-021-00828-5] [Reference Citation Analysis]
188 Kang BW, Chau I. Molecular target: pan-AKT in gastric cancer. ESMO Open. 2020;5:e000728. [PMID: 32948630 DOI: 10.1136/esmoopen-2020-000728] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
189 Bellizzi Y, Anselmi Relats JM, Cornier PG, Delpiccolo CML, Mata EG, Cayrol F, Cremaschi GA, Blank VC, Roguin LP. Contribution of endoplasmic reticulum stress, MAPK and PI3K/Akt pathways to the apoptotic death induced by a penicillin derivative in melanoma cells. Apoptosis 2021. [PMID: 34773171 DOI: 10.1007/s10495-021-01697-7] [Reference Citation Analysis]
190 Sudhesh Dev S, Zainal Abidin SA, Farghadani R, Othman I, Naidu R. Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer. Front Pharmacol 2021;12:772510. [PMID: 34867402 DOI: 10.3389/fphar.2021.772510] [Reference Citation Analysis]
191 Boehi F, Manetsch P, Hottiger MO. Interplay between ADP-ribosyltransferases and essential cell signaling pathways controls cellular responses. Cell Discov 2021;7:104. [PMID: 34725336 DOI: 10.1038/s41421-021-00323-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Joo HJ, Chung GE, Han S, Ka HI, Soh SJ, Yang Y. Adapted suspension tumor cells rewire metabolic pathways for anchorage-independent survival through AKT activation. Exp Cell Res 2022;411:113005. [PMID: 34979107 DOI: 10.1016/j.yexcr.2021.113005] [Reference Citation Analysis]
193 Ren Y, Chen J, Chen P, Hao Q, Cheong LK, Tang M, Hong LL, Hu XY, Celestial T Yap, Bay BH, Ling ZQ, Shen HM. Oxidative stress-mediated AMPK inactivation determines the high susceptibility of LKB1-mutant NSCLC cells to glucose starvation. Free Radic Biol Med 2021;166:128-39. [PMID: 33636336 DOI: 10.1016/j.freeradbiomed.2021.02.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Nenkov M, Ma Y, Gaßler N, Chen Y. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy. Int J Mol Sci 2021;22:6262. [PMID: 34200820 DOI: 10.3390/ijms22126262] [Reference Citation Analysis]
195 Ao X, Ding W, Zhang Y, Ding D, Liu Y. TCF21: a critical transcription factor in health and cancer. J Mol Med 2020;98:1055-68. [DOI: 10.1007/s00109-020-01934-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
196 Dou C, Sun L, Wang L, Cheng J, Wu W, Zhang C, Xu Q, Tu K, Liu J. Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1/AKT pathway. Cell Death Dis. 2020;11:730. [PMID: 32908135 DOI: 10.1038/s41419-020-02943-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
197 Tong C, Wang Y, Li J, Cen W, Zhang W, Zhu Z, Yu J, Lu B. Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway. Sci Rep 2021;11:4391. [PMID: 33623100 DOI: 10.1038/s41598-021-83924-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
198 Deng T, Shen P, Li A, Zhang Z, Yang H, Deng X, Peng X, Hu Z, Tang Z, Liu J, Hou R, Liu Z, Fang W. CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer. Theranostics 2021;11:8112-28. [PMID: 34335983 DOI: 10.7150/thno.54961] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
199 Qu J, Li J, Zhang Y, He R, Liu X, Gong K, Duan L, Luo W, Hu Z, Wang G, Xia C, Luo D. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway. Cell Biosci 2021;11:163. [PMID: 34419144 DOI: 10.1186/s13578-021-00677-3] [Reference Citation Analysis]
200 Dai G, Wang D, Ma S, Hong S, Ding K, Tan X, Ju W. ACSL4 promotes colorectal cancer and is a potential therapeutic target of emodin. Phytomedicine 2022;102:154149. [PMID: 35567995 DOI: 10.1016/j.phymed.2022.154149] [Reference Citation Analysis]
201 Tang J, Cheng Y, Chuang Y, Yang K, Chang F, Liu W, Chang H. Oxidative Stress and AKT-Associated Angiogenesis in a Zebrafish Model and Its Potential Application for Withanolides. Cells 2022;11:961. [DOI: 10.3390/cells11060961] [Reference Citation Analysis]
202 Samec M, Liskova A, Koklesova L, Mersakova S, Strnadel J, Kajo K, Pec M, Zhai K, Smejkal K, Mirzaei S, Hushmandi K, Ashrafizadeh M, Saso L, Brockmueller A, Shakibaei M, Büsselberg D, Kubatka P. Flavonoids Targeting HIF-1: Implications on Cancer Metabolism. Cancers (Basel) 2021;13:E130. [PMID: 33401572 DOI: 10.3390/cancers13010130] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
203 Liu Q, Dong H, Zhao W, Zhang G, Li S, Xu Q, Zhang Y. Design, Synthesis, and Biological Evaluation of APN and AKT Dual-Target Inhibitors. ACS Med Chem Lett 2021;12:1932-41. [PMID: 34917257 DOI: 10.1021/acsmedchemlett.1c00504] [Reference Citation Analysis]
204 Jones VC, Dietze EC, Jovanovic-Talisman T, McCune JS, Seewaldt VL. Metformin and Chemoprevention: Potential for Heart-Healthy Targeting of Biologically Aggressive Breast Cancer. Front Public Health 2020;8:509714. [PMID: 33194937 DOI: 10.3389/fpubh.2020.509714] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
205 Wang Z, Hulsurkar M, Zhuo L, Xu J, Yang H, Naderinezhad S, Wang L, Zhang G, Ai N, Li L, Chang JT, Zhang S, Fazli L, Creighton CJ, Bai F, Ittmann MM, Gleave ME, Li W. CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation. Neoplasia 2021;23:1147-65. [PMID: 34706306 DOI: 10.1016/j.neo.2021.09.005] [Reference Citation Analysis]
206 Varghese E, Samuel SM, Líšková A, Samec M, Kubatka P, Büsselberg D. Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer. Cancers (Basel) 2020;12:E2252. [PMID: 32806533 DOI: 10.3390/cancers12082252] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
207 Khan NH, Chen H, Fan Y, Surfaraz M, Ahammad M, Qin Y, Shahid M, Virk R, Jiang E, Wu D, Ji X. Biology of PEST‐Containing Nuclear Protein: A Potential Molecular Target for Cancer Research. Front Oncol 2022;12:784597. [DOI: 10.3389/fonc.2022.784597] [Reference Citation Analysis]
208 Zhang Y, Zhao Y, Li Q, Wang Y. Macrophages, as a Promising Strategy to Targeted Treatment for Colorectal Cancer Metastasis in Tumor Immune Microenvironment. Front Immunol 2021;12:685978. [PMID: 34326840 DOI: 10.3389/fimmu.2021.685978] [Reference Citation Analysis]
209 Eisenberg L, Eisenberg-Bord M, Eisenberg-Lerner A, Sagi-Eisenberg R. Metabolic alterations in the tumor microenvironment and their role in oncogenesis. Cancer Lett 2020;484:65-71. [PMID: 32387442 DOI: 10.1016/j.canlet.2020.04.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
210 Merckaert T, Zwaenepoel O, Gevaert K, Gettemans J. An AKT2-specific nanobody that targets the hydrophobic motif induces cell cycle arrest, autophagy and loss of focal adhesions in MDA-MB-231 cells. Biomed Pharmacother 2021;133:111055. [PMID: 33378961 DOI: 10.1016/j.biopha.2020.111055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
211 Petroni G, Buqué A, Coussens LM, Galluzzi L. Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment. Nat Rev Drug Discov 2022. [PMID: 35292771 DOI: 10.1038/s41573-022-00415-5] [Reference Citation Analysis]
212 Jahng JWS, Zhang M, Wu JC. The role of metabolism in directed differentiation versus trans-differentiation of cardiomyocytes. Semin Cell Dev Biol 2021:S1084-9521(21)00127-0. [PMID: 34074592 DOI: 10.1016/j.semcdb.2021.05.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
213 Amirani E, Hallajzadeh J, Asemi Z, Mansournia MA, Yousefi B. Effects of chitosan and oligochitosans on the phosphatidylinositol 3-kinase-AKT pathway in cancer therapy. Int J Biol Macromol 2020;164:456-67. [PMID: 32693135 DOI: 10.1016/j.ijbiomac.2020.07.137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
214 Zhang PH, Han J, Cao F, Liu YJ, Tian C, Wu CH, Smith FG, Hao Y, Jin SW. PCTR1 improves pulmonary edema fluid clearance through activating the sodium channel and lymphatic drainage in lipopolysaccharide-induced ARDS. J Cell Physiol 2020;235:9510-23. [PMID: 32529661 DOI: 10.1002/jcp.29758] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
215 Hyun SW, Imamura A, Ishida H, Piepenbrink KH, Goldblum SE, Lillehoj EP. The sialidase NEU1 directly interacts with the juxtamembranous segment of the cytoplasmic domain of mucin-1 to inhibit downstream PI3K-Akt signaling. J Biol Chem 2021;297:101337. [PMID: 34688655 DOI: 10.1016/j.jbc.2021.101337] [Reference Citation Analysis]
216 Zhang J, Song Y, Shi Q, Fu L. Research progress on FASN and MGLL in the regulation of abnormal lipid metabolism and the relationship between tumor invasion and metastasis. Front Med 2021. [PMID: 33973101 DOI: 10.1007/s11684-021-0830-0] [Reference Citation Analysis]
217 Kemp JA, Kwon YJ. Cancer nanotechnology: current status and perspectives. Nano Converg 2021;8:34. [PMID: 34727233 DOI: 10.1186/s40580-021-00282-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Luo LF, Qin LY, Wang JX, Guan P, Wang N, Ji ES. Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy. Front Pharmacol 2021;12:669782. [PMID: 34108879 DOI: 10.3389/fphar.2021.669782] [Reference Citation Analysis]
219 Khan T, Sullivan MA, Gunter JH, Kryza T, Lyons N, He Y, Hooper JD. Revisiting Glycogen in Cancer: A Conspicuous and Targetable Enabler of Malignant Transformation. Front Oncol 2020;10:592455. [PMID: 33224887 DOI: 10.3389/fonc.2020.592455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
220 Liu Y, Zhang Y, Xiao B, Tang N, Hu J, Liang S, Pang Y, Xu H, Ao J, Yang J, Liang X, Wei L, Wang Y, Luo X. MiR-103a promotes tumour growth and influences glucose metabolism in hepatocellular carcinoma. Cell Death Dis 2021;12:618. [PMID: 34131101 DOI: 10.1038/s41419-021-03905-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Rajendran P, Ben Ammar R, Al-Saeedi FJ, Elsayed Mohamed M, Islam M, Al-Ramadan SY. Thidiazuron decreases epithelial-mesenchymal transition activity through the NF-kB and PI3K/AKT signalling pathways in breast cancer. J Cell Mol Med 2020;24:14525-38. [PMID: 33159487 DOI: 10.1111/jcmm.16079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
222 Cheng X, Ge M, Zhu S, Li D, Wang R, Xu Q, Chen Z, Xie S, Liu H. mTORC1-mediated amino acid signaling is critical for cell fate determination under transplant-induced stress. FEBS Lett 2021;595:462-75. [PMID: 33249578 DOI: 10.1002/1873-3468.14008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
223 Wang L, Guo W, Guan H, Yan N, Cai X, Zhu L. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling. J Biochem Mol Toxicol 2021;:e22871. [PMID: 34338398 DOI: 10.1002/jbt.22871] [Reference Citation Analysis]
224 Udawant S, Litif C, Lopez A, Gunn B, Schuenzel E, Keniry M. PI3K Pathway Inhibition with NVP-BEZ235 Hinders Glycolytic Metabolism in Glioblastoma Multiforme Cells. Cells 2021;10:3065. [PMID: 34831287 DOI: 10.3390/cells10113065] [Reference Citation Analysis]
225 Wang C, Shi M, Ji J, Cai Q, Zhao Q, Jiang J, Liu J, Zhang H, Zhu Z, Zhang J. Stearoyl-CoA desaturase 1 (SCD1) facilitates the growth and anti-ferroptosis of gastric cancer cells and predicts poor prognosis of gastric cancer. Aging (Albany NY) 2020;12:15374-91. [PMID: 32726752 DOI: 10.18632/aging.103598] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
226 Li D, Peng W, Wu B, Liu H, Zhang R, Zhou R, Yao L, Ye L. Metallothionein MT1M Suppresses Carcinogenesis of Esophageal Carcinoma Cells through Inhibition of the Epithelial-Mesenchymal Transition and the SOD1/PI3K Axis. Mol Cells 2021;44:267-78. [PMID: 33820882 DOI: 10.14348/molcells.2021.2179] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
227 Ji J, Xu MX, Qian TY, Zhu SZ, Jiang F, Liu ZX, Xu WS, Zhou J, Xiao MB. The AKR1B1 inhibitor epalrestat suppresses the progression of cervical cancer. Mol Biol Rep 2020;47:6091-103. [PMID: 32761301 DOI: 10.1007/s11033-020-05685-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
228 Ding D, Zhong H, Liang R, Lan T, Zhu X, Huang S, Wang Y, Shao J, Shuai X, Wei B. Multifunctional Nanodrug Mediates Synergistic Photodynamic Therapy and MDSCs-Targeting Immunotherapy of Colon Cancer. Adv Sci (Weinh) 2021;8:e2100712. [PMID: 34021727 DOI: 10.1002/advs.202100712] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
229 Yang L, Li H, Yang M, Zhang W, Li M, Xu Y, Li J, Kang J, Zhang J, Guo S. Exploration in the Mechanism of Kaempferol for the Treatment of Gastric Cancer Based on Network Pharmacology. Biomed Res Int 2020;2020:5891016. [PMID: 33145355 DOI: 10.1155/2020/5891016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
230 Yang J, Huang H, Xiao D, Duan Y, Zheng Y, Chen Z. Knockdown of TMED3 inhibits cell viability and migration and increases apoptosis in human chordoma cells. Int J Oncol 2021;58:15. [PMID: 33760171 DOI: 10.3892/ijo.2021.5195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
231 Ours CA, Sapp JC, Hodges MB, de Moya AJ, Biesecker LG. Case report: five-year experience of AKT inhibition with miransertib (MK-7075) in an individual with Proteus syndrome. Cold Spring Harb Mol Case Stud 2021;7:a006134. [PMID: 34649967 DOI: 10.1101/mcs.a006134] [Reference Citation Analysis]
232 Pham DV, Park PH. Tumor Metabolic Reprogramming by Adipokines as a Critical Driver of Obesity-Associated Cancer Progression. Int J Mol Sci 2021;22:1444. [PMID: 33535537 DOI: 10.3390/ijms22031444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
233 Liu Y, Gu W. The complexity of p53-mediated metabolic regulation in tumor suppression. Semin Cancer Biol 2021:S1044-579X(21)00060-2. [PMID: 33785447 DOI: 10.1016/j.semcancer.2021.03.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
234 Braglia L, Zavatti M, Vinceti M, Martelli AM, Marmiroli S. Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target? Biochim Biophys Acta Mol Cell Res 2020;1867:118731. [PMID: 32360668 DOI: 10.1016/j.bbamcr.2020.118731] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
235 Xu C, Gu L, Kuerbanjiang M, Wen S, Xu Q, Xue H. Thrombospondin 2/Toll-Like Receptor 4 Axis Contributes to HIF-1α-Derived Glycolysis in Colorectal Cancer. Front Oncol 2020;10:557730. [PMID: 33244454 DOI: 10.3389/fonc.2020.557730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
236 Chen J, Wu Z, Ding W, Xiao C, Zhang Y, Gao S, Gao Y, Cai W. SREBP1 siRNA enhance the docetaxel effect based on a bone-cancer dual-targeting biomimetic nanosystem against bone metastatic castration-resistant prostate cancer. Theranostics 2020;10:1619-32. [PMID: 32042326 DOI: 10.7150/thno.40489] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
237 Schmidt DR, Patel R, Kirsch DG, Lewis CA, Vander Heiden MG, Locasale JW. Metabolomics in cancer research and emerging applications in clinical oncology. CA Cancer J Clin 2021;71:333-58. [PMID: 33982817 DOI: 10.3322/caac.21670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
238 De Lellis L, Veschi S, Tinari N, Mokini Z, Carradori S, Brocco D, Florio R, Grassadonia A, Cama A. Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. Cancers (Basel) 2021;13:3946. [PMID: 34439102 DOI: 10.3390/cancers13163946] [Reference Citation Analysis]
239 Lin S, Yin S, Shi J, Yang G, Wen X, Zhang W, Zhou M, Jiang X. Orchestration of energy metabolism and osteogenesis by Mg2+ facilitates low-dose BMP-2-driven regeneration. Bioactive Materials 2022;18:116-27. [DOI: 10.1016/j.bioactmat.2022.03.024] [Reference Citation Analysis]
240 Zhao F, Xu Y, Ouyang Y, Wen Z, Zheng G, Wan T, Sun G. Silencing of miR-483-5p alleviates postmenopausal osteoporosis by targeting SATB2 and PI3K/AKT pathway. Aging (Albany NY) 2021;13:6945-56. [PMID: 33621956 DOI: 10.18632/aging.202552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
241 Tamayo-Orbegozo E, Amo L, Díez-García J, Amutio E, Riñón M, Alonso M, Arana P, Maruri N, Larrucea S. Emerging Role of Podocalyxin in the Progression of Mature B-Cell Non-Hodgkin Lymphoma. Cancers (Basel) 2020;12:E396. [PMID: 32046309 DOI: 10.3390/cancers12020396] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
242 Senoo H, Murata D, Wai M, Arai K, Iwata W, Sesaki H, Iijima M. KARATE: PKA-induced KRAS4B-RHOA-mTORC2 supercomplex phosphorylates AKT in insulin signaling and glucose homeostasis. Mol Cell 2021;81:4622-4634.e8. [PMID: 34551282 DOI: 10.1016/j.molcel.2021.09.001] [Reference Citation Analysis]
243 Nishimura Y, Yamakawa D, Uchida K, Shiromizu T, Watanabe M, Inagaki M. Primary cilia and lipid raft dynamics. Open Biol 2021;11:210130. [PMID: 34428960 DOI: 10.1098/rsob.210130] [Reference Citation Analysis]
244 Zhang X, Lv S, Zhang W, Jia Q, Wang L, Ding Y, Yuan P, Zhu Y, Liu L, Li Y, Zhang J. Shenmai injection improves doxorubicin cardiotoxicity via miR-30a/Beclin 1. Biomed Pharmacother 2021;139:111582. [PMID: 33895525 DOI: 10.1016/j.biopha.2021.111582] [Reference Citation Analysis]
245 Lundt S, Zhang N, Li JL, Zhang Z, Zhang L, Wang X, Bao R, Cai F, Sun W, Ge WP, Ding S. Metabolomic and transcriptional profiling reveals bioenergetic stress and activation of cell death and inflammatory pathways in vivo after neuronal deletion of NAMPT. J Cereb Blood Flow Metab 2021;41:2116-31. [PMID: 33563078 DOI: 10.1177/0271678X21992625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
246 Sinto MS, Thomas S, Kannan S. Combinatorial treatment with Gefitinib and Bay11-7085 sensitizes primary Gefitinib-resistant OSCC cells by influencing the EGFR- NFκB signaling axis. Med Oncol 2021;38:110. [PMID: 34357463 DOI: 10.1007/s12032-021-01557-z] [Reference Citation Analysis]
247 Vaupel P, Multhoff G. Revisiting the Warburg effect: historical dogma versus current understanding. J Physiol 2021;599:1745-57. [PMID: 33347611 DOI: 10.1113/JP278810] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
248 Lang L, Lam T, Chen A, Jensen C, Duncan L, Kong FC, Kurago ZB, Shay C, Teng Y. Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib. Cells 2020;9:E533. [PMID: 32106632 DOI: 10.3390/cells9030533] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
249 Bianchini G, De Angelis C, Licata L, Gianni L. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. Nat Rev Clin Oncol 2021. [PMID: 34754128 DOI: 10.1038/s41571-021-00565-2] [Reference Citation Analysis]
250 Xue C, Li G, Lu J, Li L. Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression. Signal Transduct Target Ther 2021;6:400. [PMID: 34815385 DOI: 10.1038/s41392-021-00788-w] [Reference Citation Analysis]
251 Fusco N, Sajjadi E, Venetis K, Gaudioso G, Lopez G, Corti C, Rocco EG, Criscitiello C, Malapelle U, Invernizzi M. PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine? Genes (Basel) 2020;11:E719. [PMID: 32605290 DOI: 10.3390/genes11070719] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
252 Tan XP, He Y, Huang YN, Zheng CC, Li JQ, Liu QW, He ML, Li B, Xu WW. Lomerizine 2HCl inhibits cell proliferation and induces protective autophagy in colorectal cancer via the PI3K/Akt/mTOR signaling pathway. MedComm (2020) 2021;2:453-66. [PMID: 34766155 DOI: 10.1002/mco2.83] [Reference Citation Analysis]
253 Wang X, Wang Y, Li Z, Qin J, Wang P. Regulation of Ferroptosis Pathway by Ubiquitination. Front Cell Dev Biol 2021;9:699304. [PMID: 34485285 DOI: 10.3389/fcell.2021.699304] [Reference Citation Analysis]
254 Jiang S, Zhang E, Ruan H, Ma J, Zhao X, Zhu Y, Xie X, Han N, Li J, Zhang H, Xie W, Li X. Actinomycin V Induces Apoptosis Associated with Mitochondrial and PI3K/AKT Pathways in Human CRC Cells. Mar Drugs 2021;19:599. [PMID: 34822470 DOI: 10.3390/md19110599] [Reference Citation Analysis]
255 Pai S, Yadav VK, Kuo KT, Pikatan NW, Lin CS, Chien MH, Lee WH, Hsiao M, Chiu SC, Yeh CT, Tsai JT. PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway. Int J Mol Sci 2021;22:11492. [PMID: 34768921 DOI: 10.3390/ijms222111492] [Reference Citation Analysis]
256 Mancarella C, Morrione A, Scotlandi K. Novel Regulators of the IGF System in Cancer. Biomolecules 2021;11:273. [PMID: 33673232 DOI: 10.3390/biom11020273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
257 Xia Y, Chen R, Lu G, Li C, Lian S, Kang TW, Jung YD. Natural Phytochemicals in Bladder Cancer Prevention and Therapy. Front Oncol 2021;11:652033. [PMID: 33996570 DOI: 10.3389/fonc.2021.652033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Huang Y, Xie B, Cao M, Lu H, Wu X, Hao Q, Zhou X. LncRNA RNA Component of Mitochondrial RNA-Processing Endoribonuclease Promotes AKT-Dependent Breast Cancer Growth and Migration by Trapping MicroRNA-206. Front Cell Dev Biol 2021;9:730538. [PMID: 34621748 DOI: 10.3389/fcell.2021.730538] [Reference Citation Analysis]
259 Li F, Guo H, Liu B, Liu N, Xu Z, Wang Y, Zhou H. Explore prognostic biomarker of bladder cancer based on competing endogenous network. Biosci Rep 2020;40:BSR20202463. [PMID: 33169791 DOI: 10.1042/BSR20202463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
260 Davis TR, Pierce MR, Novak SX, Hougland JL. Ghrelin octanoylation by ghrelin O-acyltransferase: protein acylation impacting metabolic and neuroendocrine signalling. Open Biol 2021;11:210080. [PMID: 34315274 DOI: 10.1098/rsob.210080] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
261 Camaya I, Mok TY, Lund M, To J, Braidy N, Robinson MW, Santos J, O'Brien B, Donnelly S. The parasite-derived peptide FhHDM-1 activates the PI3K/Akt pathway to prevent cytokine-induced apoptosis of β-cells. J Mol Med (Berl) 2021. [PMID: 34374810 DOI: 10.1007/s00109-021-02122-x] [Reference Citation Analysis]
262 Cervellera C, Russo M, Dotolo S, Facchiano A, Russo GL. STL1, a New AKT Inhibitor, Synergizes with Flavonoid Quercetin in Enhancing Cell Death in A Chronic Lymphocytic Leukemia Cell Line. Molecules 2021;26:5810. [PMID: 34641354 DOI: 10.3390/molecules26195810] [Reference Citation Analysis]
263 Shiau J, Chuang Y, Cheng Y, Tang J, Hou M, Yen C, Chang H. Impacts of Oxidative Stress and PI3K/AKT/mTOR on Metabolism and the Future Direction of Investigating Fucoidan-Modulated Metabolism. Antioxidants 2022;11:911. [DOI: 10.3390/antiox11050911] [Reference Citation Analysis]
264 Tran DH, Kesavan R, Rion H, Soflaee MH, Solmonson A, Bezwada D, Vu HS, Cai F, Phillips JA 3rd, DeBerardinis RJ, Hoxhaj G. Mitochondrial NADP+ is essential for proline biosynthesis during cell growth. Nat Metab 2021;3:571-85. [PMID: 33833463 DOI: 10.1038/s42255-021-00374-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
265 Zhu Y, Wei W, Zhang Y, Wu J, Ma R, Feng J. Role of ATP5B in colorectal cancer. Precision Medical Sciences 2021;10:21-5. [DOI: 10.1002/prm2.12030] [Reference Citation Analysis]
266 Sun P, Zhang X, Wang RJ, Ma QY, Xu L, Wang Y, Liao HP, Wang HL, Hu LD, Kong X, Ding J, Meng LH. PI3Kα inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8+T cells and promoting fatty acid metabolism. J Immunother Cancer 2021;9:e003093. [PMID: 34373258 DOI: 10.1136/jitc-2021-003093] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
267 Krstic J, Reinisch I, Schindlmaier K, Galhuber M, Riahi Z, Berger N, Kupper N, Moyschewitz E, Auer M, Michenthaler H, Nössing C, Depaoli MR, Ramadani-muja J, Usluer S, Stryeck S, Pichler M, Rinner B, Deutsch AJA, Reinisch A, Madl T, Chiozzi RZ, Heck AJR, Huch M, Malli R, Prokesch A. Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism. Sci Adv 2022;8:eabh2635. [DOI: 10.1126/sciadv.abh2635] [Reference Citation Analysis]
268 Sun CY, Cao D, Ren QN, Zhang SS, Zhou NN, Mai SJ, Feng B, Wang HY. Combination Treatment With Inhibitors of ERK and Autophagy Enhances Antitumor Activity of Betulinic Acid in Non-small-Cell Lung Cancer In Vivo and In Vitro. Front Pharmacol 2021;12:684243. [PMID: 34267658 DOI: 10.3389/fphar.2021.684243] [Reference Citation Analysis]
269 Barés G, Beà A, Hernández L, Navaridas R, Felip I, Megino C, Blasco N, Nadeu F, Campo E, Llovera M, Dolcet X, Sanchis D. ENDOG Impacts on Tumor Cell Proliferation and Tumor Prognosis in the Context of PI3K/PTEN Pathway Status. Cancers (Basel) 2021;13:3803. [PMID: 34359707 DOI: 10.3390/cancers13153803] [Reference Citation Analysis]
270 Cucchi D, Gibson A, Martin SA. The emerging relationship between metabolism and DNA repair. Cell Cycle 2021;20:943-59. [PMID: 33874857 DOI: 10.1080/15384101.2021.1912889] [Reference Citation Analysis]
271 Khurshid S, Montes M, Comiskey DF Jr, Shane B, Matsa E, Jung F, Brown C, Bid HK, Wang R, Houghton PJ, Roberts R, Rigo F, Chandler D. Splice-switching of the insulin receptor pre-mRNA alleviates tumorigenic hallmarks in rhabdomyosarcoma. NPJ Precis Oncol 2022;6:1. [PMID: 35017650 DOI: 10.1038/s41698-021-00245-5] [Reference Citation Analysis]
272 Oyenihi OR, Oyenihi AB, Erhabor JO, Matsabisa MG, Oguntibeju OO. Unravelling the Anticancer Mechanisms of Traditional Herbal Medicines with Metabolomics. Molecules 2021;26:6541. [PMID: 34770949 DOI: 10.3390/molecules26216541] [Reference Citation Analysis]
273 Pérez-Tomás R, Pérez-Guillén I. Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment. Cancers (Basel) 2020;12:E3244. [PMID: 33153193 DOI: 10.3390/cancers12113244] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
274 Qian X, Bao ZM, Yao D, Shi Y. Lysine demethylase 5C epigenetically reduces transcription of ITIH1 that results in augmented progression of liver hepatocellular carcinoma. Kaohsiung J Med Sci 2022. [PMID: 35080113 DOI: 10.1002/kjm2.12501] [Reference Citation Analysis]
275 Abdelgawad MA, Elkanzi NA, Nayl A, Musa A, Hadal Alotaibi N, Arafa W, Gomha SM, Bakr RB. Targeting tumor cells with pyrazolo[3,4-d]pyrimidine scaffold: A literature review on synthetic approaches, structure activity relationship, structural and target-based mechanisms. Arabian Journal of Chemistry 2022. [DOI: 10.1016/j.arabjc.2022.103781] [Reference Citation Analysis]
276 Huang P, Zhu S, Liang X, Zhang Q, Luo X, Liu C, Song L. Regulatory Mechanisms of LncRNAs in Cancer Glycolysis: Facts and Perspectives. Cancer Manag Res 2021;13:5317-36. [PMID: 34262341 DOI: 10.2147/CMAR.S314502] [Reference Citation Analysis]
277 Ye T, Chen R, Zhou Y, Zhang J, Zhang Z, Wei H, Xu Y, Wang Y, Zhang Y. Salvianolic acid A (Sal A) suppresses malignant progression of glioma and enhances temozolomide (TMZ) sensitivity via repressing transgelin-2 (TAGLN2) mediated phosphatidylinositol-3-kinase (PI3K) / protein kinase B (Akt) pathway. Bioengineered 2022;13:11646-55. [PMID: 35505656 DOI: 10.1080/21655979.2022.2070963] [Reference Citation Analysis]
278 Choe JH, Mazambani S, Kim TH, Kim JW. Oxidative Stress and the Intersection of Oncogenic Signaling and Metabolism in Squamous Cell Carcinomas. Cells 2021;10:606. [PMID: 33803326 DOI: 10.3390/cells10030606] [Reference Citation Analysis]
279 Prentzell MT, Rehbein U, Cadena Sandoval M, De Meulemeester AS, Baumeister R, Brohée L, Berdel B, Bockwoldt M, Carroll B, Chowdhury SR, von Deimling A, Demetriades C, Figlia G, de Araujo MEG, Heberle AM, Heiland I, Holzwarth B, Huber LA, Jaworski J, Kedra M, Kern K, Kopach A, Korolchuk VI, van 't Land-Kuper I, Macias M, Nellist M, Palm W, Pusch S, Ramos Pittol JM, Reil M, Reintjes A, Reuter F, Sampson JR, Scheldeman C, Siekierska A, Stefan E, Teleman AA, Thomas LE, Torres-Quesada O, Trump S, West HD, de Witte P, Woltering S, Yordanov TE, Zmorzynska J, Opitz CA, Thedieck K; Genomics England Research Consortium. G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling. Cell 2021;184:655-674.e27. [PMID: 33497611 DOI: 10.1016/j.cell.2020.12.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
280 Chu B, Hong Z, Zheng X. Acylglycerol Kinase-Targeted Therapies in Oncology. Front Cell Dev Biol 2021;9:659158. [PMID: 34368119 DOI: 10.3389/fcell.2021.659158] [Reference Citation Analysis]
281 Soflaee MH, Kesavan R, Sahu U, Tasdogan A, Villa E, Djabari Z, Cai F, Tran DH, Vu HS, Ali ES, Rion H, O’hara BP, Kelekar S, Hallett JH, Martin M, Mathews TP, Gao P, Asara JM, Manning BD, Ben-sahra I, Hoxhaj G. Purine nucleotide depletion prompts cell migration by stimulating the serine synthesis pathway. Nat Commun 2022;13. [DOI: 10.1038/s41467-022-30362-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
282 Fusco N, Malapelle U, Fassan M, Marchiò C, Buglioni S, Zupo S, Criscitiello C, Vigneri P, Dei Tos AP, Maiorano E, Viale G. PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer. Front Oncol 2021;11:644737. [PMID: 33842357 DOI: 10.3389/fonc.2021.644737] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
283 Dang X, Qin Y, Gu C, Sun J, Zhang R, Peng Z. Knockdown of Tripartite Motif 8 Protects H9C2 Cells Against Hypoxia/Reoxygenation-Induced Injury Through the Activation of PI3K/Akt Signaling Pathway. Cell Transplant 2020;29:963689720949247. [PMID: 32841049 DOI: 10.1177/0963689720949247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
284 Bowry A, Kelly RDW, Petermann E. Hypertranscription and replication stress in cancer. Trends Cancer 2021;7:863-77. [PMID: 34052137 DOI: 10.1016/j.trecan.2021.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
285 Osan C, Chira S, Nutu AM, Braicu C, Baciut M, Korban SS, Berindan-Neagoe I. The Connection between MicroRNAs and Oral Cancer Pathogenesis: Emerging Biomarkers in Oral Cancer Management. Genes (Basel) 2021;12:1989. [PMID: 34946938 DOI: 10.3390/genes12121989] [Reference Citation Analysis]
286 Li H, Prever L, Hirsch E, Gulluni F. Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer. Cancers (Basel) 2021;13:3517. [PMID: 34298731 DOI: 10.3390/cancers13143517] [Reference Citation Analysis]
287 Reiter RJ, Sharma R, Rosales-Corral S. Anti-Warburg Effect of Melatonin: A Proposed Mechanism to Explain its Inhibition of Multiple Diseases. Int J Mol Sci 2021;22:E764. [PMID: 33466614 DOI: 10.3390/ijms22020764] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
288 Ji Z, Liu GH, Qu J. Mitochondrial sirtuins, metabolism, and aging. J Genet Genomics 2021:S1673-8527(21)00358-1. [PMID: 34856390 DOI: 10.1016/j.jgg.2021.11.005] [Reference Citation Analysis]
289 Roskoski R Jr. Properties of FDA-approved small molecule phosphatidylinositol 3-kinase inhibitors prescribed for the treatment of malignancies. Pharmacol Res 2021;168:105579. [PMID: 33774181 DOI: 10.1016/j.phrs.2021.105579] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
290 D'Oto A, Fang J, Jin H, Xu B, Singh S, Mullasseril A, Jones V, Abu-Zaid A, von Buttlar X, Cooke B, Hu D, Shohet J, Murphy AJ, Davidoff AM, Yang J. KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma. Nat Commun 2021;12:7204. [PMID: 34893606 DOI: 10.1038/s41467-021-27502-2] [Reference Citation Analysis]
291 Takahashi M, Hasegawa Y, Maeda K, Kitano M, Taniguchi N. Role of glycosyltransferases in carcinogenesis; growth factor signaling and EMT/MET programs. Glycoconj J 2022. [PMID: 35089466 DOI: 10.1007/s10719-022-10041-3] [Reference Citation Analysis]
292 Wu F, Chen Z, Liu J, Hou Y. The Akt-mTOR network at the interface of hematopoietic stem cell homeostasis. Exp Hematol 2021;103:15-23. [PMID: 34464661 DOI: 10.1016/j.exphem.2021.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
293 Belaidi AA, Masaldan S, Southon A, Kalinowski P, Acevedo K, Appukuttan AT, Portbury S, Lei P, Agarwal P, Leurgans SE, Schneider J, Conrad M, Bush AI, Ayton S. Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy. Mol Psychiatry 2022. [PMID: 35484240 DOI: 10.1038/s41380-022-01568-w] [Reference Citation Analysis]
294 Liu G, Ma JY, Hu G, Jin H. Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients. PLoS One 2021;16:e0254368. [PMID: 34252149 DOI: 10.1371/journal.pone.0254368] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
295 Giannopoulou AF, Velentzas AD, Anagnostopoulos AK, Agalou A, Papandreou NC, Katarachia SA, Koumoundourou DG, Konstantakou EG, Pantazopoulou VI, Delis A, Michailidi MT, Valakos D, Chatzopoulos D, Syntichaki P, Iconomidou VA, Tsitsilonis OE, Papassideri IS, Voutsinas GE, Hatzopoulos P, Thanos D, Beis D, Anastasiadou E, Tsangaris GT, Stravopodis DJ. From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis. Cancers (Basel) 2021;13:2024. [PMID: 33922182 DOI: 10.3390/cancers13092024] [Reference Citation Analysis]
296 Zhou YQ, Sun Y, Luo HL, Gao ZF, Zhang HQ, Meng QG, Bai XY, Hou GG, Hou Y. Discovery of anti-hepatoma agents from 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine by inhibiting PI3K/AKT/NF-κB pathway activation. Eur J Med Chem 2021;225:113796. [PMID: 34450496 DOI: 10.1016/j.ejmech.2021.113796] [Reference Citation Analysis]
297 Yelek C, Mignion L, Paquot A, Bouzin C, Corbet C, Muccioli GG, Cani PD, Jordan BF. Tumor Metabolism Is Affected by Obesity in Preclinical Models of Triple-Negative Breast Cancer. Cancers 2022;14:562. [DOI: 10.3390/cancers14030562] [Reference Citation Analysis]
298 Mthembu SXH, Mazibuko-Mbeje SE, Ziqubu K, Nyawo TA, Obonye N, Nyambuya TM, Nkambule BB, Silvestri S, Tiano L, Muller CJF, Dludla PV. Impact of physical exercise and caloric restriction in patients with type 2 diabetes: Skeletal muscle insulin resistance and mitochondrial dysfunction as ideal therapeutic targets. Life Sci 2022;297:120467. [PMID: 35271881 DOI: 10.1016/j.lfs.2022.120467] [Reference Citation Analysis]
299 Wen J, Qin L, Chen G, Huang H, Shen M, Pang J, Tang Y, Lu W, Wang R, Luo J, Rai SN. Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation. Disease Markers 2022;2022:1-13. [DOI: 10.1155/2022/7962220] [Reference Citation Analysis]
300 Chevalier B, Dupuis H, Jannin A, Lemaitre M, Do Cao C, Cardot-Bauters C, Espiard S, Vantyghem MC. Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations. Front Endocrinol (Lausanne) 2021;12:678869. [PMID: 34025587 DOI: 10.3389/fendo.2021.678869] [Reference Citation Analysis]
301 Duan S, Pagano M. Ubiquitin ligases in cancer: Functions and clinical potentials. Cell Chem Biol 2021;28:918-33. [PMID: 33974914 DOI: 10.1016/j.chembiol.2021.04.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
302 Mehta KJ. Role of iron and iron-related proteins in mesenchymal stem cells: Cellular and clinical aspects. J Cell Physiol 2021;236:7266-89. [PMID: 33821487 DOI: 10.1002/jcp.30383] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
303 Chen Y, Li Y, Huang L, Du Y, Gan F, Li Y, Yao Y. Antioxidative Stress: Inhibiting Reactive Oxygen Species Production as a Cause of Radioresistance and Chemoresistance. Oxid Med Cell Longev 2021;2021:6620306. [PMID: 33628367 DOI: 10.1155/2021/6620306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
304 N Chin C, Subhawong T, Grosso J, Wortman JR, McIntosh LJ, Tai R, Braschi-Amirfarzan M, Castillo P, Alessandrino F. Teaching cancer imaging in the era of precision medicine: Looking at the big picture. Eur J Radiol Open 2022;9:100414. [PMID: 35309874 DOI: 10.1016/j.ejro.2022.100414] [Reference Citation Analysis]
305 Li L, Yin Y, Nan F, Ma Z. Circ_LPAR3 promotes the progression of oral squamous cell carcinoma (OSCC). Biochem Biophys Res Commun 2021;589:215-22. [PMID: 34922206 DOI: 10.1016/j.bbrc.2021.12.012] [Reference Citation Analysis]
306 Huang L, Guo Z, Wang F, Fu L. KRAS mutation: from undruggable to druggable in cancer. Signal Transduct Target Ther 2021;6:386. [PMID: 34776511 DOI: 10.1038/s41392-021-00780-4] [Reference Citation Analysis]
307 Meerstein-Kessel L, Venhuizen J, Garza D, Proellochs NI, Vos EJ, Obiero JM, Felgner PL, Sauerwein RW, Peters M, Yang ASP, Huynen MA. Novel insights from the Plasmodium falciparum sporozoite-specific proteome by probabilistic integration of 26 studies. PLoS Comput Biol 2021;17:e1008067. [PMID: 33930021 DOI: 10.1371/journal.pcbi.1008067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
308 Murugesan N, Maitituoheti M. KMT2D deficiency confers a therapeutic vulnerability to glycolytic and IGFR inhibitors in melanoma. Mol Cell Oncol 2021;8:1984827. [PMID: 34859145 DOI: 10.1080/23723556.2021.1984827] [Reference Citation Analysis]
309 Martorana F, Motta G, Pavone G, Motta L, Stella S, Vitale SR, Manzella L, Vigneri P. AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? Front Pharmacol 2021;12:662232. [PMID: 33995085 DOI: 10.3389/fphar.2021.662232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
310 Fernandes SA, Demetriades C. The Multifaceted Role of Nutrient Sensing and mTORC1 Signaling in Physiology and Aging. Front Aging 2021;2:707372. [DOI: 10.3389/fragi.2021.707372] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
311 Butera A, Roy M, Zampieri C, Mammarella E, Panatta E, Melino G, D'Alessandro A, Amelio I. p53-driven lipidome influences non-cell-autonomous lysophospholipids in pancreatic cancer. Biol Direct 2022;17:6. [PMID: 35255936 DOI: 10.1186/s13062-022-00319-9] [Reference Citation Analysis]
312 Zhang C, Liu J, Wang J, Zhang T, Xu D, Hu W, Feng Z. The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer. Front Cell Dev Biol 2021;9:648808. [PMID: 33681231 DOI: 10.3389/fcell.2021.648808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
313 Cha Y, Kim T, Jeon J, Jang Y, Kim PB, Lopes C, Leblanc P, Cohen BM, Kim KS. SIRT2 regulates mitochondrial dynamics and reprogramming via MEK1-ERK-DRP1 and AKT1-DRP1 axes. Cell Rep 2021;37:110155. [PMID: 34965411 DOI: 10.1016/j.celrep.2021.110155] [Reference Citation Analysis]
314 He L, Tang L, Wang R, Liu L, Zhu P, Jiang K, Tu G. Long noncoding RNA KB-1980E6.3 promotes breast cancer progression through the PI3K/AKT signalling pathway. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153891] [Reference Citation Analysis]
315 Wongkularb S, Limboonreung T, Tuchinda P, Chongthammakun S. Suppression of PI3K/Akt/mTOR pathway in chrysoeriol-induced apoptosis of rat C6 glioma cells. In Vitro Cell Dev Biol Anim 2021. [PMID: 34907494 DOI: 10.1007/s11626-021-00634-x] [Reference Citation Analysis]
316 Duggan MR, Weaver M, Khalili K. PAM (PIK3/AKT/mTOR) signaling in glia: potential contributions to brain tumors in aging. Aging (Albany NY) 2021;13:1510-27. [PMID: 33472174 DOI: 10.18632/aging.202459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
317 Ni C, Li B, Ding Y, Wu Y, Wang Q, Wang J, Cheng J. Anti-Cancer Properties of Coix Seed Oil against HT-29 Colon Cells through Regulation of the PI3K/AKT Signaling Pathway. Foods 2021;10:2833. [PMID: 34829119 DOI: 10.3390/foods10112833] [Reference Citation Analysis]
318 Mishra R, Gupta Y, Ghaley G, Bhowmick NA. Functional Diversity of Macropinocytosis. Subcell Biochem 2022;98:3-14. [PMID: 35378700 DOI: 10.1007/978-3-030-94004-1_1] [Reference Citation Analysis]
319 Li RL, He LY, Zhang Q, Liu J, Lu F, Duan HX, Fan LH, Peng W, Huang YL, Wu CJ. HIF-1α is a Potential Molecular Target for Herbal Medicine to Treat Diseases. Drug Des Devel Ther 2020;14:4915-49. [PMID: 33235435 DOI: 10.2147/DDDT.S274980] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
320 Park JH, Pyun WY, Park HW. Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets. Cells 2020;9:E2308. [PMID: 33081387 DOI: 10.3390/cells9102308] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
321 Meleddu R, Deplano S, Maccioni E, Ortuso F, Cottiglia F, Secci D, Onali A, Sanna E, Angeli A, Angius R, Alcaro S, Supuran CT, Distinto S. Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives. J Enzyme Inhib Med Chem 2021;36:685-92. [PMID: 33602041 DOI: 10.1080/14756366.2021.1887171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
322 Peng Y, Wang Y, Zhou C, Mei W, Zeng C. PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway? Front Oncol 2022;12:819128. [DOI: 10.3389/fonc.2022.819128] [Reference Citation Analysis]
323 Micaily I, Roche M, Ibrahim MY, Martinez-Outschoorn U, Mallick AB. Metabolic Pathways and Targets in Chondrosarcoma. Front Oncol 2021;11:772263. [PMID: 34938658 DOI: 10.3389/fonc.2021.772263] [Reference Citation Analysis]
324 Wang WY, Wu WY, Li AL, Liu QS, Sun Y, Gu W. Synthesis, anticancer evaluation and mechanism studies of novel indolequinone derivatives of ursolic acid. Bioorg Chem 2021;109:104705. [PMID: 33618252 DOI: 10.1016/j.bioorg.2021.104705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
325 Ghasemi Z, Tahmasebi-Birgani MJ, Ghafari Novin A, Motlagh PE, Teimoori A, Ghadiri A, Pourghadamyari H, Sarli A, Khanbabaei H. Fractionated radiation promotes proliferation and radioresistance in bystander A549 cells but not in bystander HT29 cells. Life Sci 2020;257:118087. [PMID: 32702442 DOI: 10.1016/j.lfs.2020.118087] [Reference Citation Analysis]
326 Yang F, Xuan G, Chen Y, Cao L, Zhao M, Wang C, Chen E. MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Colorectal Cancer. Front Cell Dev Biol 2022;10:828128. [DOI: 10.3389/fcell.2022.828128] [Reference Citation Analysis]
327 Liu X, Chang Q, Wang H, Qian H, Jiang Y. Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer. Breast Cancer 2021;28:806-21. [PMID: 33475963 DOI: 10.1007/s12282-021-01215-2] [Reference Citation Analysis]
328 Mokhtari RB, Qorri B, Baluch N, Sparaneo A, Fabrizio FP, Muscarella LA, Tyker A, Kumar S, Cheng HM, Szewczuk MR, Das B, Yeger H. Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis. Oncotarget 2021;12:1470-89. [PMID: 34316328 DOI: 10.18632/oncotarget.28011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
329 Mottaghi S, Abbaszadeh H. The anticarcinogenic and anticancer effects of the dietary flavonoid, morin: Current status, challenges, and future perspectives. Phytother Res 2021. [PMID: 34498311 DOI: 10.1002/ptr.7270] [Reference Citation Analysis]
330 Wang Z, Lv J, Li X, Lin Q. The flavonoid Astragalin shows anti-tumor activity and inhibits PI3K/AKT signaling in gastric cancer. Chem Biol Drug Des 2021. [PMID: 34396710 DOI: 10.1111/cbdd.13933] [Reference Citation Analysis]
331 Zou N, Zhang X, Li S, Li Y, Zhao Y, Yang X, Zhu S. Elevated HNF1A expression promotes radiation-resistance via driving PI3K/AKT signaling pathway in esophageal squamous cell carcinoma cells. J Cancer 2021;12:5013-24. [PMID: 34234870 DOI: 10.7150/jca.58023] [Reference Citation Analysis]
332 Goker Bagca B, Ozates NP, Asik A, Caglar HO, Gunduz C, Biray Avci C. Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells. Biochem Biophys Res Commun 2020;533:1497-504. [PMID: 33109342 DOI: 10.1016/j.bbrc.2020.10.058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
333 Moon S, Kim M, Kim Y, Lee S. Supplementation with High or Low Iron Reduces Colitis Severity in an AOM/DSS Mouse Model. Nutrients 2022;14:2033. [DOI: 10.3390/nu14102033] [Reference Citation Analysis]
334 Yao H, He S. Multi‑faceted role of cancer‑associated adipocytes in the tumor microenvironment (Review). Mol Med Rep 2021;24:866. [PMID: 34676881 DOI: 10.3892/mmr.2021.12506] [Reference Citation Analysis]
335 Kalayci Yigin A, Azzawri A, Ozturk K, Cora T, Seven M. Determination of cytokine profile and associated genes of the signaling pathway in HNSCC. J Recept Signal Transduct Res 2021;:1-7. [PMID: 34886759 DOI: 10.1080/10799893.2021.2013888] [Reference Citation Analysis]
336 Limberger T, Schlederer M, Trachtová K, Garces de Los Fayos Alonso I, Yang J, Högler S, Sternberg C, Bystry V, Oppelt J, Tichý B, Schmeidl M, Kodajova P, Jäger A, Neubauer HA, Oberhuber M, Schmalzbauer BS, Pospisilova S, Dolznig H, Wadsak W, Culig Z, Turner SD, Egger G, Lagger S, Kenner L. KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis. Mol Cancer 2022;21:89. [PMID: 35354467 DOI: 10.1186/s12943-022-01542-8] [Reference Citation Analysis]
337 Zhang Y, Fang C, Bao H, Yuan W, Lu H. Discover the Post‐Translational Modification Proteome Using Mass Spectrometry. Chin J Chem 2021;39:550-8. [DOI: 10.1002/cjoc.202000515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
338 Perry J, Ashford B, Thind AS, Gauthier ME, Minaei E, Major G, Iyer NG, Gupta R, Clark J, Ranson M. Comprehensive Mutational and Phenotypic Characterization of New Metastatic Cutaneous Squamous Cell Carcinoma Cell Lines Reveal Novel Drug Susceptibilities. Int J Mol Sci 2020;21:E9536. [PMID: 33333825 DOI: 10.3390/ijms21249536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
339 Li A, Li S, Zhang C, Fang Z, Sun Y, Peng Y, Wang X, Zhang M. FPR2 serves a role in recurrent spontaneous abortion by regulating trophoblast function via the PI3K/AKT signaling pathway. Mol Med Rep 2021;24:838. [PMID: 34608500 DOI: 10.3892/mmr.2021.12478] [Reference Citation Analysis]
340 Lim Y, Kim S, Yoon HN, Ku NO. Keratin 8/18 Regulate the Akt Signaling Pathway. Int J Mol Sci 2021;22:9227. [PMID: 34502133 DOI: 10.3390/ijms22179227] [Reference Citation Analysis]
341 Kotta AS, Kelling AS, Corleto KA, Sun Y, Giles ED. Ghrelin and Cancer: Examining the Roles of the Ghrelin Axis in Tumor Growth and Progression. Biomolecules 2022;12:483. [DOI: 10.3390/biom12040483] [Reference Citation Analysis]
342 Huang N, Zhao G, Yang Q, Tan J, Tan Y, Zhang J, Cheng Y, Chen J. Intracellular and extracellular S100A9 trigger epithelial-mesenchymal transition and promote the invasive phenotype of pituitary adenoma through activation of AKT1. Aging (Albany NY) 2020;12:23114-28. [PMID: 33203795 DOI: 10.18632/aging.104072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
343 Lin S, Meng Y, Cao C, Wu P, Gao P, Zhi W, Peng T, Wu P. Comprehensive analysis of LDHAP5 pseudogene expression and potential pathogenesis in ovarian serous cystadenocarcinoma. Cancer Cell Int 2020;20:229. [PMID: 32536817 DOI: 10.1186/s12935-020-01324-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
344 Martínez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer 2021. [PMID: 34272515 DOI: 10.1038/s41568-021-00378-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
345 Oliveira GL, Coelho AR, Marques R, Oliveira PJ. Cancer cell metabolism: Rewiring the mitochondrial hub. Biochim Biophys Acta Mol Basis Dis 2021;1867:166016. [PMID: 33246010 DOI: 10.1016/j.bbadis.2020.166016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
346 Wang Q, Wang P, Qin Z, Yang X, Pan B, Nie F, Bi H. Altered glucose metabolism and cell function in keloid fibroblasts under hypoxia. Redox Biol 2021;38:101815. [PMID: 33278780 DOI: 10.1016/j.redox.2020.101815] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
347 Yang K, Wu Z, Zhang H, Zhang N, Wu W, Wang Z, Dai Z, Zhang X, Zhang L, Peng Y, Ye W, Zeng W, Liu Z, Cheng Q. Glioma targeted therapy: insight into future of molecular approaches. Mol Cancer 2022;21:39. [PMID: 35135556 DOI: 10.1186/s12943-022-01513-z] [Reference Citation Analysis]
348 Basu A, Lambring CB. Akt Isoforms: A Family Affair in Breast Cancer. Cancers (Basel) 2021;13:3445. [PMID: 34298660 DOI: 10.3390/cancers13143445] [Reference Citation Analysis]
349 Deleyto-Seldas N, Efeyan A. The mTOR-Autophagy Axis and the Control of Metabolism. Front Cell Dev Biol 2021;9:655731. [PMID: 34277603 DOI: 10.3389/fcell.2021.655731] [Reference Citation Analysis]
350 Dockx Y, Vangestel C, Van den Wyngaert T, Huizing M, De Bruycker S, Pauwels P, Staelens S, Stroobants S. Early Changes in [18F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts. Mol Imaging 2021;2021:5594514. [PMID: 34113218 DOI: 10.1155/2021/5594514] [Reference Citation Analysis]
351 He J, Chen M, Xu J, Fang J, Liu Z, Qi H. Identification and characterization of Piwi-interacting RNAs in human placentas of preeclampsia. Sci Rep 2021;11:15766. [PMID: 34344990 DOI: 10.1038/s41598-021-95307-w] [Reference Citation Analysis]
352 Dotolo S, Cervellera C, Russo M, Russo GL, Facchiano A. Virtual Screening of Natural Compounds as Potential PI3K-AKT1 Signaling Pathway Inhibitors and Experimental Validation. Molecules 2021;26:492. [PMID: 33477701 DOI: 10.3390/molecules26020492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
353 Pang L, Shah H, Xu Y, Qian S. Delta-5-desaturase: A novel therapeutic target for cancer management. Transl Oncol 2021;14:101207. [PMID: 34438249 DOI: 10.1016/j.tranon.2021.101207] [Reference Citation Analysis]
354 Liu L, Yan H, Ruan M, Yang H, Wang L, Lei B, Sun X, Chang C, Huang G, Xie W. An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth. Cancer Sci 2021;112:3083-98. [PMID: 34033176 DOI: 10.1111/cas.14988] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
355 Chilamakuri R, Rouse DC, Yu Y, Kabir AS, Muth A, Yang J, Lipton JM, Agarwal S. BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy. Transl Oncol 2022;15:101272. [PMID: 34823094 DOI: 10.1016/j.tranon.2021.101272] [Reference Citation Analysis]
356 Pan F, Wang K, Zheng M, Ren Y, Hao W, Yan J, Wang J. A TRP Family Based Signature for Prognosis Prediction in Head and Neck Squamous Cell Carcinoma. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/8757656] [Reference Citation Analysis]
357 Zhou X, Guo Y, Yang K, Liu P, Wang J. The signaling pathways of traditional Chinese medicine in promoting diabetic wound healing. J Ethnopharmacol 2022;282:114662. [PMID: 34555452 DOI: 10.1016/j.jep.2021.114662] [Reference Citation Analysis]
358 Saklani P, Khan H, Gupta S, Kaur A, Singh TG. Neuropeptides: Potential neuroprotective agents in ischemic injury. Life Sci 2022;288:120186. [PMID: 34852271 DOI: 10.1016/j.lfs.2021.120186] [Reference Citation Analysis]
359 Guo C, Gao C, Lv X, Zhao D, Greenaway FT, Hao L, Tian Y, Liu S, Sun MZ. CRKL promotes hepatocarcinoma through enhancing glucose metabolism of cancer cells via activating PI3K/Akt. J Cell Mol Med 2021;25:2714-24. [PMID: 33523562 DOI: 10.1111/jcmm.16303] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
360 Yao X, Mei Y, Mao W. Quercetin Improves Mitochondrial Function and Inflammation in H2O2-Induced Oxidative Stress Damage in the Gastric Mucosal Epithelial Cell by Regulating the PI3K/AKT Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:1386078. [PMID: 34873406 DOI: 10.1155/2021/1386078] [Reference Citation Analysis]
361 Feng L, Feng S, Nie Z, Deng Y, Xuan Y, Chen X, Lu Y, Liang L, Chen Y. TRAF6 Promoted Tumor Glycolysis in Non-Small-Cell Lung Cancer by Activating the Akt-HIFα Pathway. Biomed Res Int 2021;2021:3431245. [PMID: 34409101 DOI: 10.1155/2021/3431245] [Reference Citation Analysis]
362 Petroni G, Buqué A, Zitvogel L, Kroemer G, Galluzzi L. Immunomodulation by targeted anticancer agents. Cancer Cell 2021;39:310-45. [PMID: 33338426 DOI: 10.1016/j.ccell.2020.11.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
363 Bim LV, Carneiro TNR, Buzatto VC, Colozza-Gama GA, Koyama FC, Thomaz DMD, de Jesus Paniza AC, Lee EA, Galante PAF, Cerutti JM. Molecular Signature Expands the Landscape of Driver Negative Thyroid Cancers. Cancers (Basel) 2021;13:5184. [PMID: 34680332 DOI: 10.3390/cancers13205184] [Reference Citation Analysis]
364 Ascenção K, Szabo C. Emerging roles of cystathionine β-synthase in various forms of cancer. Redox Biology 2022. [DOI: 10.1016/j.redox.2022.102331] [Reference Citation Analysis]
365 Dobens LL, Nauman C, Fischer Z, Yao X. Control of Cell Growth and Proliferation by the Tribbles Pseudokinase: Lessons from Drosophila. Cancers (Basel) 2021;13:883. [PMID: 33672471 DOI: 10.3390/cancers13040883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
366 Zhan YT, Li L, Zeng TT, Zhou NN, Guan XY, Li Y. SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma. Aging (Albany NY) 2020;13:537-54. [PMID: 33289700 DOI: 10.18632/aging.202164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
367 Yu Y, Xie Z, Zhao M, Lian X. Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer. BMC Cancer 2021;21:368. [PMID: 33827485 DOI: 10.1186/s12885-021-08115-w] [Reference Citation Analysis]
368 Sajjadi E, Venetis K, Piciotti R, Gambini D, Blundo C, Runza L, Ferrero S, Guerini-Rocco E, Fusco N. Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling. BMC Cancer 2021;21:1152. [PMID: 34706703 DOI: 10.1186/s12885-021-08889-z] [Reference Citation Analysis]
369 Ruan Y, Fang X, Guo T, Liu Y, Hu Y, Wang X, Hu Y, Gao L, Li Y, Pi J, Xu Y. Metabolic reprogramming in the arsenic carcinogenesis. Ecotoxicol Environ Saf 2021;229:113098. [PMID: 34952379 DOI: 10.1016/j.ecoenv.2021.113098] [Reference Citation Analysis]
370 Senoo H, Wai M, Matsubayashi HT, Sesaki H, Iijima M. Hetero-oligomerization of Rho and Ras GTPases Connects GPCR Activation to mTORC2-AKT Signaling. Cell Rep 2020;33:108427. [PMID: 33238110 DOI: 10.1016/j.celrep.2020.108427] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]